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                                                        Abstract  
 
Background: Pregnant women with Type 1 diabetes mellitus develop vascular 
lesions similar to atheroma in the placental bed. These lesions are characterised by an 
accumulation of activated macrophages around spiral arteries, where they can 
stimulate a vigorous inflammatory reaction and impair vascular integrity and threaten 
blood flow. Diabetic pregnancies carry a high risk of development and rapid 
progression of preeclampsia and decreased placental blood flow causing fetal growth 
restriction. 
 
 In the development of the vascular lesions, peripheral blood monocytes are recruited, 
adhere to endothelium and migrate to subendothelial space where they initiate an 
inflammatory response. These events are mediated by surface adhesion molecules on 
both monocytes and endothelial cells. Earlier work from our research group had 
shown increased in vitro adherence of monocytes from diabetic pregnancy to decidual 
endothelial cells from normal pregnancies,  
 
Experiments described in this thesis explore further the mechanisms subserving this 
abnormal monocyte adherence to decidual endothelium in diabetic pregnancy. After 
initial studies comparing adhesion molecule expression by monocytes from normal 
and diabetic pregnancies, the role of monocyte-derived Mac-1 in monocyte-decidual 
endothelial cell adherence was further investigated by the use of a blocking antibody.  
 
Methods: Mixed peripheral blood mononuclear cells from three groups of pregnant 
3rd trimester subjects, (i) normal, (ii) gestational diabetes, and (iii) type I diabetes, 
were isolated by density gradient centrifugation through Ficoll-Paque. Monocytes 
were identified (CD 14+) and their adhesion molecule expression (LFA-1, Mac-1, 
VLA-4) determined by double staining flow cytometry.  
 
DECs were isolated from decidual biopsies collected from normally pregnant women 
at elective caesarean section. For subsequent flow cytometry, DECs were identified  
CD45-, and their ICAM-1 expression was measured by double staining flow 
cytometry. A highly enriched population of monocytes was then isolated (by density 
gradient centrifugation through iodixanol) from the blood of normally and type I 
 ix 
diabetic pregnant women. Monocytes underwent incubation under basal and 
stimulated conditions followed by a further incubation with or without a blocking 
antibody to Mac-1. Monocytes were then co-cultured with DECs, and their adhesion 
and expression of Mac-1 were assessed.  
 
Results: Monocytes from type I diabetic pregnancies displayed increased expression 
of Mac-1 and LFA-1 but not VLA-4. Adhesion molecule expression in gestational 
diabetes was between normal and type 1 diabetes. There was no significant direct 
correlation with adequacy of diabetic control as assessed by concomitantly measured 
blood glucose or HbA1c levels across the three groups in this study.  
LPS pre-treatment of monocytes from normal pregnancy caused an increase in Mac-1 
expression and was associated with an increase in their adherence to normal DECs.  
ICAM-1 expression by normal DECs was stimulated by the presence of adherent 
monocytes, but no further increase in this ICAM-1 expression was seen when the 
monocytes had been pre-stimulated by LPS.  
 
Exposure of monocytes from normal pregnancy to high levels of glucose also caused 
an increase in Mac-1 expression, associated with an increase in their adherence to 
normal DECs. The cause-and-effect nature of this Mac-1 expression was shown by 
monocyte pre-treatment with a Mac-1 monoclonal antibody, which prevented their 
adhesion to DECs in both basal and stimulated conditions, both in normal and in type 
I diabetic pregnancy. 
 
Conclusion: The increased adhesion molecule expression of monocytes from type I 
diabetic pregnancy is paralleled by their increased adhesion to decidual endothelium, 
and may be causally involved in production of placental bed vascular disease in 
diabetic pregnancy .Pre-treatment of monocytes with stimuli that increased Mac-1 
expression resulted in an increase in their adhesion to decidual endothelium, an effect 
prevented by specific Mac-1 antibody blockade. The experiments conducted in this 
study examine only a part of the adhesion interaction of monocytes and decidual 
endothelial cells. While monocyte Mac-1 expression is clearly of central importance, 
other factors are involved, some resulting from the initiation of monocyte adherence, 
such as the observed DEC-derived ICAM-1 which may amplify the adhesion. Other 
 x 
adhesion molecules could be involved, as could be the release of chemo-attractant 
peptides.  
 
These results add significantly to our earlier report of increased adhesion of 
monocytes from pregnant woman with type I diabetes to normal decidual endothelial 
cells, and provide evidence related to the mechanisms subserving this increased 
adhesion. 
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1.  Introduction  
 
            The studies described in this thesis, conducted in cells obtained from pregnant 
human subjects, examine the relationship between endothelial cells of the placental 
bed and the circulating precursors of their surrounding macrophages, peripheral blood 
monocytes. The overall aim of these studies was to clarify the patho-physiological 
processes that result in the atheromatous vascular pathology seen in the placental bed 
in pregnancies complicated by diabetes mellitus. 
 
             
As background to this work, there follows a review of pertinent literature, including:  
 
(i)   A summary of development of the early placenta. 
(ii) A review of monocyte function, with particular reference to their adhesion 
molecule production  
(iii)  A description of the lesions of atheroma, and of the potential involvement of the 
immune system, in particular monocytes, in their production. 
(iv)   An outline of the increase in such vascular pathology seen in diabetes. 
(v)   Aspects of diabetes and the immune system in pregnancy 
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1.1  Development of the Placenta  
 
The placenta is the fetus’s extension into the mother, and functions as the 
crossing point between the two. It is a vital and exceptional organ, which allows cells 
of fetal origin to come into direct contact with maternal blood, to facilitate exchange 
of oxygen and carbon dioxide, to provide nutrients required for fetal growth and 
development, and to remove fetal waste products.  
 
The principal cells of the human placenta –the trophoblasts– first appear four to seven 
days after fertilization as the outer layer of cells of the blastocyst. These early 
blastocyst trophoblasts differentiate into all other cell types found in the human 
placenta. Trophoblasts are crucial for successful pregnancy, by mediating such steps 
as implantation, hormone production, immune protection of the fetus, and regulation 
of maternal vascular blood flow into the placenta (Moore, 1993). 
 
1.1.1 Early Development 
 
Within a few days of fertilization the embryo develops into a blastocyst  
(Figure 1.1), a globular structure composed on the outside of trophoblasts and on the 
inside of an assembly of cells called the inner cell mass (Figure 1.1). The inner cell 
mass will eventually develop into the fetus. In addition to making human chorionic 
gonadotrophin (hCG), trophoblasts mediate the implantation process by first attaching 
to, and then invading into the endometrium. (Kliman, 1994, 1986) 
 
 
Figure 1.1: Blastocyst 
Trophoblast 
 
Inner cell mass 
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The most difficult task for the floating blastocyst is to become attached to the lining 
of the uterine cavity (endometrium). The blastocyst is initially held in place by 
specific long molecules that extend from the endometrium (mucins), followed by a 
flow of molecules that convey the trophoblasts into closer and closer contact with the 
endometrium. Once intimate contact is made trophoblasts invade into the 
endometrium, beginning the process of placentation. 
 
1.1.2 Formation of the early placenta 
 
By nine days after fertilization the blastocyst (embryo) is surrounded by two 
layers of trophoblasts: the inner mononuclear cytotrophoblasts and the outer 
multinucleated syncytiotrophoblast layer, both of which remain throughout gestation. 
During the first 2 weeks of development, the syncytiotrophoblast forms lacunae that 
encircle the blastocyst. At the same time, they penetrate the endometrial blood 
vessels, to form inter-trophoblastic maternal blood filled sinuses, which surround the 
growing trophoblasts.  
 
On day 13 the primitive villous structure appears, and the basic structure of the villous 
tree is established, which continues to develop throughout gestation (Figure 1.1.2) 
(Sadler, 1990) 
 
 
 
 
Figure 1.2:  Two week implantation site 
 
 
 
Trophoblastic lacunae 
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Figure 1.3:  Three week implantation site 
Within the placenta the syncytiotrophoblasts produce high levels of hCG 
which shifts cytotrophoblast differentiation towards a non-invasive, hormone 
secreting, villous-type cell. The nearer the trophoblasts are to the endometrium the 
less hCG is made, allowing the trophoblasts to differentiate into anchoring type cells 
which formulate the placental ‘glue’, the protein trophouteronectin. Trophoblasts that 
leave the placenta and migrate within the endo- and myometrium are induced to make 
proteases and protease inhibitors, presumably to facilitate trophoblast regulation of 
invasion into maternal tissues (Lee, 1986). 
 
The trophoblastic shell continues to grow and proliferate to increase the surface area 
for maternal-fetal interchange and allow floating villi to bathe directly in maternal 
blood, and start chorionic villi formation (Loke, 1990). By week 3 embryonic tissue 
and maternal blood are separated by a layer of cytotrophoblasts and 
syncytiotrophoblasts. During that time the villous syncytiotrophoblasts secrete vital 
hormones such as progesterone, estrogen and hCG, hormones critical for maintaining 
pregnancy (Conley and Mason, 1990)  
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The chorionic villi next to the maternal blood supply will continue to develop 
and enlarge into an accumulation of chorionic tissue, which we categorize as the 
placenta. The chorionic villi farthest away from the maternal blood supply are 
gradually pushed into the uterine hollow by the growing amnionic sac which 
surrounds the embryo. These villi eventually degenerate and form the chorionic layer 
of the external membranes.  
 
At around 12 to 14 weeks of gestation the combined amnion—chorion membrane 
makes contact with the opposite side of the uterus, where it fuses with the 
decidualised maternal endometrium and the extra embryonic coelom is usually 
obliterated by the expanding amnion by 10 to 11 weeks.  
 
 
  
 
 
Figure 1.4: Terminal chorionic villus. 
 
The fetal circulation branches until it reaches the capillaries of the chorionic villi 
where exchange of nutrients takes place between the mother and fetus. 
Associated with the general expansion of placental construction is the differentiation 
of three different trophoblast types (Kliman, 1986) (Kurman, 1984). Depending on 
their eventual function in vivo, undifferentiated cytotrophoblasts can expand into the 
following: 
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1)  Hormonally active villous syncytiotrophoblasts, that secrete the majority of 
placental hormones, such as hCG, which is essential to  early pregnancy since it 
rescues the corpus luteum from involution, thus maintaining progesterone 
production by the ovarian granulosa cells.(Conley and Mason, 1990) 
 
2)  Extravillous anchoring trophoblastic cell columns. They form the second type of 
trophoblast–the junctional trophoblast.  These cells form the anchoring cell 
columns that can be seen at the junction of the placenta and endometrium 
throughout gestation. 
3)  Invasive intermediate trophoblasts within the villi of the human placenta. There 
always exists a population of cytotrophoblasts which remain undifferentiated and 
available for differentiation as necessary. 
 
 
Biologically, trophoblast-mediated vascular remodelling within the placental bed 
allows for marked distensibility of the uteroplacental vessels, thus accommodating the 
increased blood flow needed during gestation. Abnormalities in this invasive process 
have been correlated with early and mid-trimester pregnancy loss, vascular disease, 
preeclampsia and eclampsia, and intrauterine growth restriction 
 
1.1.3  Maternal and Fetal cells - genetically and immunologically different. 
  
The body’s immune system is unique in its ability to differentiate between the 
body’s own tissues, and unfamiliar invaders, such as micro-organisms (Paul, 1993).  
This ‘self’ versus ‘non-self’ discrimination is best illustrated by the clinical outcomes 
of solid organ transplantation.  Donor grafts that are matched to the recipient’s “tissue 
types” result in successful transplantation, whereas mismatched transplants are 
rejected. Rejection is mediated by highly polymorphic molecules encoded in a genetic 
region termed the major histocompatibility complex (MHC) or HLA complex in 
humans. Transplant rejection is primarily mediated by T lymphocytes that are also 
responsible for cell-mediated immunity. T cells can recognize molecules encoded 
within the MHC, such as MHC class I or class II molecules, and can recognize and be 
stimulated by foreign MHC molecules expressed on the transplanted tissue, resulting 
in rejection. 
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Generally, fetal trophoblast cells are in contact with the maternal circulation and 
should be subject to attack by circulating maternal T cells if paternal MHC molecules 
are perceived as foreign. One obvious violation of the classic transplantation 
paradigm is the case of a mother’s successful ability to maintain a fetus in the womb. 
This maternal–fetal “tolerance” is such a notable exception that it has evaded most 
attempts to explain it. Among the possibilities are that the uterus is an 
immunologically advantaged site, protected from the immune system, or that maternal 
immune responses are immunosuppressed during pregnancy (Janeway, 1996, 2002) 
(Tafuri, 1995).  
 
Studies over the last few years have shown that maternal–fetal tolerance may be due 
to a specific and direct interaction (or lack thereof) between fetal and maternal cells 
Rouas and colleagues (Rouas, 1997) provided new evidence involving an MHC class 
I-like molecule termed HLA-G and natural killer (NK) cells, adding significantly to 
an emerging literature that implicates these seemingly unrelated molecules and cells. 
 
1.2      The Immune system 
 
1.2.1 Introduction  
 
The human immune system is a complex set of pathways that allow the human 
body to react to foreign invaders such as infectious agents or antigenically different 
cells. The human immune system is divided broadly into innate and adaptive arms, 
described in more detail below.  
  
1.2.2   The innate immune system 
 
The innate arm of the immune system is an ancient, well conserved protective 
pathway, not targeted to specific pathogens, but primed for immediate broad range 
defence. It recognizes a range of pathogen-associated molecular patterns present in 
many different micro-organisms. These include lipopolysaccharide of the gram-
negative bacterial cell wall, peptidoglycans, lipotechoic acids from the gram-positive 
bacterial cell wall, the sugar mannose (common in microbial glycolipids and 
glycoproteins but rare in humans), bacterial DNA, N-formylmethionine found in 
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bacterial proteins, double-stranded RNA from viruses, and glucans from fungal cell 
walls. (Borghnas, 1999, Medzhitov R. 2001).  
 
The innate immune responses involve:  
 
(i) phagocytic cells (neutrophils, monocytes, and macrophages),  
 
(ii) cells that release inflammatory mediators (basophiles, mast cells, and 
eosinophils), natural killer cells (NK cells);  
 
(iii) molecules such as complement proteins and cytokines. 
 
A detailed consideration of all of these components is outside the scope of the present 
body of work. Since the studies performed examined aspects of the involvement of 
monocytes/macrophages in development of placental bed vascular pathology in 
diabetic pregnancy, there follows a summary of the function and role of cells of this 
lineage. 
 
1.2.2.1 Phagocytic cells 
 
Monocytes and macrophages are classified as cells of the reticulo-endothelial 
system (RES). Early in the 19th century, Van Furth anticipated the mononuclear 
phagocyte system (MPS), and monocytes and macrophages were recognised as basic 
cell types of this system. Their maturity takes place in the bone marrow and passes 
through the following steps: stem cell - committed stem cell - monoblast - 
promonocyte - monocyte (bone marrow) - monocyte (peripheral blood) - macrophage 
(tissues).  
Monocyte differention in the bone marrow proceeds rapidly (1.5 to 3 days). During 
differentiation, granules are formed in monocyte cytoplasm and these can be divided  
into at least two types. 
 
Blood monocytes are young cells that possess migratory, chemotactic, pinocytic and 
phagocytic activities, as well as receptors for IgG Fc-domains (Fc R) and iC3b 
complement. Monocytes go through additional differentiation (at least one day in 
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duration) to become multifunctional tissue macrophages. Monocytes are generally, 
therefore, considered to be immature macrophages. However, it can be argued that 
monocytes represent the circulating macrophage population and should be considered 
fully functional for their location, changing phenotype in response to factors 
encountered in specific tissue after migration. (Aschoff, 1924). 
Macrophages can be separated into normal and inflammatory macrophages. Normal 
macrophages are found in several sites, including connective tissue (histiocytes), 
lymph nodes (free and fixed macrophages), spleen (free and fixed macrophages), liver 
(Kupffer's cells), lung (alveolar macrophages), bone marrow (fixed macrophages), 
serous fluids (pleural and peritoneal macrophages), and skin (histiocytes, 
Langerhans's cell). (Van Furth, 1971) 
The macrophage population in a particular tissue is maintained by three mechanisms: 
arrival of monocytes from the circulating blood, local production and biological 
turnover. Under normal conditions, the renewal of tissue macrophages occurs through 
local proliferation of progenitor cells and not via monocyte influx. Tissue 
macrophages are relatively long-lived cells. Depending on the type of tissue, their 
viability ranges between 6 and 16 days.  
1.2.2.2  Human peripheral blood monocyte subsets 
 
Monocytes account for 3-8% of the circulating leucocyte population, and are 
the largest of the white cells (up to 20 μm) in diameter. They are highly motile and 
actively phagocytic. Monocytes are characterised by a large, eccentrically placed 
nucleus that stains less intensely than that of other leucocytes. Nuclear indentation 
becomes more pronounced as the cells mature, giving the cell a horseshoe appearance. 
The cytoplasm contains a variable number of ribosomes and polyribosomes, and 
monocytes are capable of continuous ribosomal activity. They are members of the 
human mononuclear phagocyte system, important for non-specific defence against 
pathogenic organisms and tumour surveillance. Various subtypes are diverse in 
phenotype and purpose, all generated from CD34+ myeloid progenitors. Upstream in 
the myeloid lineage there exists a myelo-dendritic progenitor cell from which 
monocytes, granulocytes and CD14-derived dendritic cells all derive (Santiago, 1999). 
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In peripheral blood, it is possible to find not only mature monocytes  and granulocytes 
but also precursor cells such as CD34+ progenitor cells (Bender, 1991) (Mattern, 
1999) that may experience additional differentiation depending on the local 
environment. When tissue damage occurs, cytokines and chemokines are produced 
and transport activation signals for the recruitment of different leukocytes to the 
inflammatory site (Scapini, 2002). Monocytes receiving such a stimulus enter the 
inflamed tissue and differentiate into macrophages (Qiao, 1996) ( Wintergerst, 1998). 
 
Akiyama distinguished a major population of so-called {regular monocytes} > 80% 
and a minor subset of {intermediate Mo} < 10% ( Akiyama, 1983, 1985). 
The regular monocytes are categorized by bigger size, higher expression of the 
monocyte-specific surface antigen OKM1 and higher accessory capacity in mitogen-
induced T cell proliferation.  
 
They exhibit higher peroxidase activity and higher antibody-dependent cell-mediated 
cytotoxicity (ADCC) than intermediate Mo, whereas the intermediate monocyte is 
more easily mobilized from extravascular reservoirs. The regular monocytes release a 
larger amount of prostaglandin E2 (PGE2), interleukin-1 (IL-1) and colony-stimulating 
factor (CSF) than intermediate monocytes, which produce more interferon-  (IFN- ) 
(Yasaka, 1981). 
 
Weiner identified a population of larger cells with higher myeloperoxidase (MPO) 
activity, higher superoxide production in response to zymosan, and higher CSF-
producing capacity compared to a subset of small cells with high cytotoxicity toward 
heterologous tumours (Weiner, 1984).  
 
Also, different monocyte subsets with regard to cytokine production have been 
reported, showing that Mo of high-density fractions from Percoll-gradient 
preparations release more IL-1 than cells of low-density fractions (Fernandez, 1986). 
Definition of monocyte subsets has generally been based on their differences in 
surface marker expression. Monocyte subsets are phenotypically recognized  by their 
differential expression of Fc R alone or in combination with other surface markers 
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and functions. Mo expressing Fc R-I and -II, but not those expressing Fc R-III, have 
been reported to mediate ADCC efficiently (Connor, 1990).  
Fc R-I has been found on the majority of monocytes. Similar to the regular Mo 
described above (Chechimi, 1989), these cells are large cells, represent potent 
phagocytes (Grage, 1993) and produce higher amounts of pro-inflammatory cytokines 
such as IL-1, IL-6, tumour necrosis factor (TNF- ) (Szabo (a), 1990), and also higher 
amounts of PGE2 , which in turn is known to suppress APC function and T cell 
activity (Pryjma, 1992)(Zembala, 1984, 1986). Large monocytes express higher 
chemotactic activity than small Mo, the Fc R-I Mo has been defined as the main 
population expressing receptors for C5a and N-formyl-methionyl-leucyl-
phenylalanine (fMLP) (Ohura, 1987). Separation of monocytes based on size and 
density results in subsets that share characteristics with subsets defined by Fc R 
expression but are not the same. 
Rather than Fc R-I, Fc R-III is expressed only on a small subset of 
monocytes, and Ziegler-Heitbrock has described phenotypic and functional 
differences for those Mo that express or lack Fc R-III (Ziegler-Heitbrock, 1991, 
1992). Accordingly, the majority of Mo express the surface marker CD14 and appear 
as CD14+  low HLA-DR-expressing phagocytic cells with high producing capacity for 
reactive oxygen radicals and pro-inflammatory cytokines (Ziegler, 1991, 1993).  
Also, regular CD14+subsets differ in their expression of the scavenger receptor and in 
receptor-mediated binding of low-density lipoprotein (LDL). CD14+cells exhibit 
higher expression of Sc-receptor class A type I/II and also stronger LDL binding. A 
recent study also revealed differences in the chemokines receptor expression and 
chemotactic activity of these subsets. CD14+ cells show expression of CCR2 that is 
paralleled with higher chemotactic migration responsiveness for monocyte 
chemotactic protein-1, (Webber, 2000).   
Studies on the size and density of Mo in the blood of healthy human donors have 
identified a major subset of large high-density Mo and minor subsets of less dense 
cells. The major subset is represented by Fc R-I Mo (Szabo (b), 1990) (Pryjma, 1985, 
1986, 1992) (Crage, 1993), which are identical to CD14+ Mo. These cells are classical 
monocytes with typical phenotype and functions such as high cytokine production 
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(Schinkel, 1998), high chemotactic (Ohura, 1987) and phagocytic activity (Craige, 
1993). In contrast, the different minor subsets of small less dense cells are more 
heterogeneous than the major typical monocyte population, and their phenotypic and 
functional characterization reveals common features with macrophages and myeloid 
or lymphoid dendritic cells.  
The phenotypic and functional dissociation between blood Mo subsets, indicates 
differences in their immunoregulatory roles: the major subset of typical large, high-
density Fc R-I Mo represents potent phagocytes that are active in the innate immune 
response against pathogens and are finally responsible for the down-regulation of an 
established immune response.  
Their high expression of chemotactic ligand receptors indicates high susceptibility to 
chemotactic agents and chemokines and enables their early recruitment to the site of 
inflammation where they produce high amounts of proinflammatory cytokines leading 
to recruitment and activation of other monocytes and other effector cells, and 
therefore, promotion of an early inflammatory response. Furthermore, the relative 
resistance of Fc R-I monocytes to T cell killing (Frankenberger, 1996), provides the 
possibility of prolonged T cell inflammatory responses.  
CD 14 was previously reported to be a LPS- binding receptor which is distributed on 
the cell surface and enhances the LPS signals. But since CD 14 lacks a cytoplasmic 
domain, it may not be responsible for the signal transduction. Recently, Toll like 
receptors (TLR), which are type-I transmembrane proteins expressed on immune cells 
such as macrophages, monocytes and dendritic cells, have been found to be major 
signalling receptors of the innate immune system. TLR recognise pathogen- specific 
molecules by their extracellular leucine-rich repeat (LRR) domains, and activate the 
signalling cascade via cytoplasmic Toll/IL-1 receptor (TIR) domains, leading to the 
synthesis of inflammatory mediators, like cytokines or nitric oxide. To date more than 
ten members of the TLR family have been found. Among them, TLR4 is recognised 
as an LPS receptor. 
In conclusion, this variety within the blood monocyte populations may reflect their 
different states of activation and/or differentiation, enabling them to induce rapid 
innate and long-lasting adaptive immune responses.  
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1.2.2.3   Monocyte adhesion molecules 
 
Cell adhesion occurs when a plasma membrane adhesion receptor interacts 
with a molecule in the extracellular matrix or on the neighbouring cell and when the 
liganded receptor forms a connection with the cell’s own cytoskeleton. The process is 
controlled by the expression and function of adhesion receptors and by encounter with 
the corresponding ligands. Since monocyte migration to the perivascular space (where 
they can initiate and perpetuate inflammatory lesions) must be preceded by adherence 
of the cells to the endothelium, it is of particular importance to understand the 
regulation of this adherence, governed by the production of adhesion molecules. 
 
Adhesion molecule classification  
 
The immunoglobulin gene superfamily (Ig): These are type I transmembrane proteins, 
which may be classified in different subfamilies according to structural and functional 
homologies. The family comprises more than 70 members. The criterion for inclusion 
of a protein in this family is the presence of one or more Ig domains. They are 
expressed generally in leucocytes and endothelium (Ranscht, 1994). Members of the 
immunoglobulin superfamily bind to other members of the superfamily, to integrins 
or to a diverse range of additional counter-receptors. (Davies, 1993) (Garrod, 1993). 
 
The Selectins: These are a small family represented by only three members, those 
expressed on leucocytes (L-selectin), on platelets (P-selectin) and on endothelium (P 
and E selectin)(Adams, 1994). They bind to carbohydrates and are constructed from 
three types of protein domains. One of the major functions of selectins is support of 
leucocytes rolling on endothelium (Lasky, 1995) (Westphal, 1992) 
 
The integrins: The name integrin was coined to signify the presumed role of these 
proteins in integrating the intracellular cytoskeleton with the extracellular matrix 
(Ruoslahti, 1990). They are a family of membrane glycoproteins, consisting of two 
subunits - alpha and beta heterodimers. The β subunits are the main mediators of cell-
extracellular matrix adhesion (for example laminin, collagens), and they are also 
involved in cell-cell adhesion. Sixteen α chains and eight β chains have been 
characterised. 
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These associate to form 21 different integrin α / β heterodimers, each showing a 
defined ligand binding specificity. The integrins were originally classified into three 
subfamilies: (beta1 integrins, beta 2 and beta 3 integrins) in which a common beta 
subunit was thought to associate with a number of different alpha subunits, but this 
classification is not very realistic because until now at least 12 different alpha 
subunits and 8 beta subunits have been identified.  
The ligand binding site of integrins appears to be from both subunits and their 
cytoplasmic domains form connections with the cytoskeleton endowing integrins with 
the ability to serve as a link between the cytoskeleton and the extracellular matrix 
(Westphal, 1992) (Hynes, 1992). 
 
Kishimoto (1989) has shown that three developments underscore the importance of 
leucocyte integrins as adhesion receptors of the immune system: 
 
• Recognition that these integrins are evolutionarily related to other integrins, 
such as fibronectin receptor and platelet glycoprotein, which guide cell 
localization during embryogenesis and wound healing. The leucocyte integrins 
provide a similar mechanism in the immune system for guiding leucocyte 
localization during inflammation. 
 
• Identification of intercellular adhesion molecule-1 (ICAM-1),- a ligand for the 
integrin family member LFA-1 ( leucocyte function associated antigen), which 
is induced during inflammation and can regulate  leucocyte migration and 
localization. This receptor-ligand pair revealed the first known interaction 
between a member of the integrin family (LFA-1) and a member of the 
immunoglobulin family (ICAM-1). 
 
• Discovery of immunodeficiency patients genetically deficient in expression of 
the leucocyte integrins 
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1.2.2.4    Adhesion regulation and signalling 
 
There is evidence that abnormal cellular immunity, in particular monocyte 
dysfunction, is central to the development of premature and accelerated vascular 
disease or atheroma in general, and that this is most marked in diabetic patients. Early 
in the development of atheromatous lesions, monocytes are preferentially recruited to 
the arterial intima (Schwartz et al, 1991) (Ross, 1986) (Gerrity, 1981), bind to and 
migrate across the endothelium. Even in the normal situation, there is a low 
background level of this monocyte adhesion and transendothelial migration  This 
process ensures maintenance of the macrophage population in the interstitial space, 
where they may be needed at short notice for phagocytic purposes. In the presence of 
inflammatory stimuli, the adhesiveness of monocytes is markedly increased as is the 
recruitment of additional monocytes to augment the resident tissue macrophage 
population (Issekutz, 1981) (Blusse Van Oud (1983)). 
 
Monocytes express a higher level of adhesion to endothelial cells than do 
granulocytes or lymphocytes (Beekhiuzen, 1990, 1991) ( Wallis, 1985). As they tend 
to accumulate along the peripheral membrane of individual endothelial cells, it is 
likely that the surfaces of both cells are more adhesive at the periphery. This has led 
to speculation about the role of specific adhesion molecules in this process.  
 
The B2 integrins (MAC-1, LFA-1 and VLA-4) are expressed exclusively on 
leucocytes and particularly on monocytes and so play a vital role in intercellular 
reaction involving these immune cells  ((Khishimoto, 1989) (Arnaout, 1990). 
Insufficient expression of these adhesion molecules on monocytes is accompanied by 
impairment of immune surveillance (Arnaout, 1990). The central role of these 
integrins has been shown in experiments using function perturbing antibodies. 
Blocking of MAC-1 and LFA-1 by specific monoclonal antibodies results in a fall in 
extravasation of macrophages to the interstitial space, resulting in impairment of some 
aspects of local immune function. 
 
Monocytes express a variety of adhesion molecules, each of which plays a vital role 
in their interactions with endothelial cells. Some, like L-selectin, primarily mediate 
and regulate rolling of monocytes along the endothelium,), while others have more 
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direct effects on adhesion. These latter effects, and their regulation, are the subject of 
my study and a more detailed description of the molecules involved directly in 
monocyte adhesion follows . 
 
Three members of the B2 integrin subfamily (MAC-1, LFA-1 and VLA-4) have been 
identified to play a crucial role in the adhesion of monocytes to endothelial cells, . 
 
MAC-1 
 
MAC -1 consists of a 170 Kd α− subunit and a 95 Kd β− subunit and is expressed on 
monocytes, and to a lesser degree on granulocytes. The expression of β2  integrin  
MAC-1 is increased significantly after acute hyperglycaemia in both normal and type 
2 diabetic subjects (Sampson 2002), and there is a significant increase of MAC-1 on 
stimulated and unstimulated diabetic monocytes compared with normal (Dosquet 
1992). Kunt and colleagues found that monocytes of normolipidemic hyperglycaemic 
type 1 diabetes express higher level of MAC-1   (Kunt 1999). 
 
 
LFA-1 
 
LFA-1 consists of a 180-Kd α subunit and a 95-Kd β subunit, is expressed on 
leucocytes and particularly on monocytes (Krensky, 1983) (Lanier 1985), and has 
been shown to participate significantly in monocyte interactions with endothelial cells 
(Velde, 1987) ( Dustin, 1988) 
LFA-1 plays an important role in the pathogenesis of type I diabetes (Mysliwiec 
1999), while in pregnant animals with alloxan-induced diabetes, blocking the B2 
integrin component (LFA-1) involved in binding to ICAM-1 on decidual endothelial 
cells, has been shown to result in significantly reduced monocyte binding (Jeong 
1994). 
Kretowski found that the expression of monocyte LFA-1 is increased in type I 
diabetes (Kretowski 1999) and Patrizia found that there is upregulation of monocyte 
LFA-1 expression in normal human pregnancy (Patrizia 2002) 
Koller et al found an upregulation of monocyte LFA-1 expression in inflammatory 
conditions such as osteoarthritis rheumatoid arthritis 
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 ( Koller 1999), and revealed that upregulation of this adhesion molecule is vital for 
the development of inflammatory processes, explaining the changes of expression  
and upregulation of LFA-1 on monocytes in diabetic pregnant subjects.  
 
VLA-4 
 
VLA-4 is expressed on monocytes and lymphocytes, and has been shown to 
contribute to their adhesion to VCAM-1 on endothelial cells (Beekhuizen, 1992) 
(Osborn, 1989) (Carlos, 1990) 
 
The pathogenesis of adoptive autoimmune diabetes requires an interaction between 
VLA-4 on monocytes and VCAM-1 on DEC, Baron et al have used antibodies to 
block VLA-4 on monocytes and one of its ligands and VCAM-1 on DEC, and they 
were able to delay the onset of diabetes and decrease its incidence in adoptive transfer 
model. The binding of VLA-4 and VCAM-1 is very important in the development  of 
IDDM (Baron 1993), so what could be the  role of VLA-4 in the development of 
atheroma in T1DM pregnancy?   Another scholar found that Blocking VLA-4 on 
monocyte using monoclonal antibody inhibited the ability of high glucose and 
Lipoxegenase to induce monocyte adhesion to endothelium (Patrizia 1999). 
 
After rolling along the endothelium and light adherence, monocyte must adhere firmly 
to the endothelial cell. The regulation of adhesion at the level of receptor-ligand 
interactions involves modulation of receptor number and type. This occurs by 
synthesis, secretion from intracellular stores or by increased expression of the 
integrins. Regulation of integrin functions by affinity modulation through allosteric 
conformational changes is of major biological significance. These changes are 
thought to be elicited after cell activation by the interaction of specific cytosolic or 
cytoskeletal proteins with the cytoplasmic tails of the cell’s integrin receptor 
(Diamond, 1994). The β subunit of integrin plays an important role in this affinity 
regulation since epitopes for integrin activation antibodies lie on the β chain. 
Antibodies may affect integrin function by direct stimulation of conformational 
changes or by an allosteric effect, (ie by binding to the epitope in the β chain induced 
or attenuated in the ligand-occupied integrin), thereby stabilising the active or the 
inactive conformation (Mould, 1996). 
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1.2.3 The adaptive immune system 
 
If an invading pathogen escapes the innate defences, the body can launch a 
more sophisticated adaptive or specific response against one type of antigen. 
 
Adaptive immunity refers to antigen-specific defence mechanisms that take several 
days to become protective and are designed to remove a specific antigen. This is the 
immunity one develops throughout life. There are two major branches of the adaptive 
immune responses: cell-mediated and humoral (Medzhitov, 1997).  
 
 
1.2.3.1  Cell-mediated immunity 
 
Cell-mediated immunity does not engage antibodies, but, mediated by T-
lymphocytes, involves the production of cytotoxic T-lymphocytes, activated 
macrophages, activated NK cells, and cytokines in response to an antigen (Welle, 
1997).  
 
Its functions include:  
 
• Phagocytosis and killing of intracellular pathogens  
• Direct cell killing by cytotoxic T cells  
• Direct cell killing by NK and K cells (Palucka, 1999)  
 
These responses are particularly important for destroying intracellular bacteria, 
eliminating viral infections and destroying tumour cells. While the production of 
antibody through the humoral immune response can effectively lead to the elimination 
of a variety of pathogens, micro-organisms that have evolved to invade and multiply 
within phagocytic cells of the immune response pose a different threat.  
 
The cell-mediated immune response is also involved in rejection of foreign grafts and 
the elimination of tumours and virus-infected cells. The effector cells involved in 
these processes are cytotoxic T-lymphocytes (CTLs) and NK-cells. 
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1.2.3.2 Humoral immunity 
 
Humoral immunity involves the creation of antibodies in response to an 
antigen and is mediated by B-lymphocytes.  The first stage in this pathway is the 
phagocytosis of foreign matter by macrophages. The macrophages digest the 
infectious agent and then display some of its components on their surfaces. The 
helper-T cells recognize this presentation, activate their immune response, and 
multiply rapidly, inducing the activation phase. 
 
The next phase, the effector phase, involves a communication between helper-T cells 
and B-cells. Activated helper-T cells use signals to contact B-cells, which then 
multiply rapidly. B-cell descendants become either plasma cells or B memory cells. 
The plasma cells manufacture huge quantities of antibodies that will bind to the 
antigen and prime it for destruction. B memory cells retain a "memory" of the specific 
antigen that can be used to mobilize the immune system faster if the body encounters 
the same antigen later in life (Borghans, 1999). 
 
1.2.4  Immune system  changes in diabetic patients 
 
Spatz has described an impaired proliferative response of CD4+ T cells to 
primary antigens in patients with type I diabetes (Spatz, 2003). Also he showed that 
monocyte-derived dendritic cells from this group of patients  expressed elevated 
levels of CD 86 and reduced amounts of the adhesion molecule CD54 on their cell 
surface compared to control subjects and patients with type II diabetes (Spatz, 2003), 
He found that monocytes stimulated with lipopolysaccharide (LPS), produced high 
levels of the anti inflammatory cytokines interleukin IL-10 and IL-6 (Spatz, 2003). 
 
Studies investigating the behavior of adhesion molecules in diabetic pregnant patients, 
revealed that levels of E selectin, MAC-1 were significantly higher in type II diabetic 
pregnant patients compared with clinically normal pregnancy (Pertynska, 2000). 
Higher expression of VCAM-1 has been described in patients with diabetes compared 
with the normal population (Rasmussen, 2002), and serum from diabetic patients has 
been shown to contain components capable of inducing VCAM-1 expression in 
endothelial cells independent of hyperglycemia. These findings indicate that 
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augmented induction of endothelial VCAM-1 expression by circulating factors may 
play a role in the development of atherosclerosis in diabetes ((Rasmussen, 2002). 
 
Gibson found a significant increase in the expression of E selectin and ICAM-1 in 
nonpregnant diabetic women compared with nonpregnant normal women, while the 
vascular endothelial cell adhesion molecule VCAM-1 concentration changed 
significantly in pregnancy in diabetic women only (Gibson, 1997). 
 
1.3 Atherosclerosis 
 
`The definition of atherosclerosis: Clogging, narrowing, and hardening of the 
body's large arteries and medium-sized blood vessels in response to multiple 
pathogenic factors. Atherosclerosis is a disease of the arterial wall in which the intima 
is thickened, resulting in narrowing of the lumen and thus impairment of blood flow. 
 
The arterial wall consists of the following layers:  
 
(i)  the innermost (lining the vessel cavity) monolayer of endothelial cells, which is 
separated from the intima by a basement membrane consisting of connective 
tissue  
 
(ii)  the middle layer, the media, consisting of smooth muscle cells (SMCs), and 
finally  
 
(iii)  an outer connective tissue layer, the adventitia, which embeds the vessel in its 
surroundings.(Stary, 1994)  
 
Atherosclerotic lesions emerge in the intima as ‘fatty streaks’, cushion-like lipid-rich 
elevations protruding into the lumen, the earliest stages of the disease that later 
develops into atherosclerotic plaques  
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Atherosclerosis is an end-stage vascular pathology with a compound 
pathophysiological structure. Atherosclerosis represents a particular type of 
thickening and hardening (sclerosis) of the arterial wall that is also characterized by 
the presence of ‘foam cells’ (lipid-laden macrophages and smooth muscle cells 
(SMCs)) that may burst and discharge their filling into the lesional areas.  
 
These severe lesions have a particular propensity to rupture at the edges, the so-called 
shoulder regions, aggravate thrombus formation, and thus lead to such final 
complications as myocardial infarction or stroke. Although arteriosclerosis is the 
wider term for these various forms of the disease, including atherosclerosis, the latter 
designation is now the generally accepted term (Stary, 1995). 
 
Atherosclerosis is multifactorial with an extensive list of potential causative factors.  
These include: 
  
(i)  high levels of LDL-cholesterol or oxidised LDL. The altered-lipoprotein 
hypothesis postulates an initiating role of chemically altered lipoproteins, most 
Figure 1.5: Microscopic appearance of the inner surface of a human artery. 
I, normal artery; F, fatty streak; P, raised plaque; E, exulcerated plaque, 
The insert in the lower right corner shows immunohistochemical staining 
of CD3+ T lymphocytes in the shoulder region of an early atherosclerotic 
lesion.  Taken from (Stary, 1995) 
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notably oxLDL, in forming foam cells and acting as chemoattractants for SMCs 
and mononuclear cells into the intima (Steinberg 1989, Witztum 2001)  
 
(ii)  free radicals (eg caused by cigarette smoking),  
 
(iii)  hyperglycemia and advanced glycation end-products (AGE). Accelerated by 
hyperglycemia, AGE accumulation is believed to contribute to the gradual 
development of diabetic complications 
 
(iv)  infectious agents (Saiku, 1988).  
 
(v)  stress. 
The increased incidence of atherosclerotic complications seen during the 
grieving process has been attributed to the development of stress-induced 
hyperlipidemia, hormone dysfunction, and the increased shear stress of 
hypertension, which together injures the endothelium and modifies the 
environment of the endothelial barrier to the passage of blood constituents 
(Ross 1976, Saiku, 1988). 
 
(vi) genetic vulnerability to endothelial damage (Shi, 2000).  
 
(vii)    an immunological origin (Wick 1995, Wick 1997 ). 
This causation is suggested by the results of immunohistological examination of 
very early atheromatous changes not sufficiently advanced to cause clinical 
symptoms. It has been shown that the first cell types found in the arterial intima 
at sites known to be predisposed for later development of atherosclerotic lesions 
are lymphoid cells, followed by macrophages and SMCs (Xu, 1990). 
 
This last potential mechanism is examined in more detail below. 
 
1.3.1 Atherosclerosis:  an immune system disorder?  
 
The association of inflammatory processes (reflected by increased levels of C-
reactive protein (CRP) with an increased risk for atherosclerosis is well-recognised 
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(Ridker 2000, Ridker 2001, Kiechel 2001). Witztum has described defence from 
atherosclerosis by natural antibodies with a certain idiotype (D15) focussed against 
oxLDL (Horkko, 1999). Natural antibodies are generated without known antigenic 
stimulation and belong to the IgM type produced by a special subset of innate B 
lymphocytes, the B1 cells. These cells are characterized by the expression of 
restricted germline-encoded B cell receptors conveying specificity for natural or self-
antigens. Natural antibodies have been shown to bind oxidized phospholipids, such as 
palmytoyl 1-2 (5-oxo-valeroyl)-sn glycerol-3 phosphorylcholine (POVPC), and serve 
to remove oxLDL, thus preventing its uptake by macrophages.  
 
Wiztum suggests that a natural selection process for Bl cells secreting oxidation-
specific D15 antibodies has been operative, both for their role in natural immune 
defence and for housekeeping purposes against oxidation-dependent epitopes under 
healthy and pathologic conditions.  
 
In early immunohistochemical studies (the Pathobiological Determinants of 
Atherosclerosis in Youth (PDAY) study), there was an opportunity to  analyse arterial 
specimens from more than 3000 arterial fragments collected from young subjects who 
died from non-cardiovascular causes. The authors found CDIa DC (dendritic cells) in 
the intima of all subjects. Because DC forms a link between the innate and the 
adaptive immune systems, it is of interest that Aicher  (Aicher, 2003) described a 
strong DC-activating potential of nicotine. This is reflected by the expression of co-
stimulatory molecules (CD86, CD40) and MHC class II and adhesion molecules 
(LFA-I, CD54), and a sevenfold increase in secretion of the pro-inflammatory Th-1-
activating cytokine IL-12. The PDAY study specimens contained substantial numbers 
of CD19+ B cells, depending on, and growing with severity of lesions. 
 
 
1.3.1.1 The role of the innate immune system in the development of 
atherosclerosis 
 
Cells of the innate immune system, in response to immune challenge, produce 
a set of highly conserved molecules known as peroxisome proliferator-activated 
receptors (PPARs) . The range of PPARs produced by cells of the innate defence 
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system is based on a natural selection of germline-encoded genes and includes) and 
collectins (mannan-binding lectin, surfactant). Probably fewer than 100 different 
types of receptors exist, each recognising restricted patterns of entire classes of 
pathogen ligands, called pathogen-associated molecular patterns (PAMPs). PAMPs 
are present not only on the surface of pathogens, but also in solution, e.g., as bacterial 
endotoxins (LPS), denatured proteins, bacterial and denatured eukaryotic DNAs, and 
a variety of other compounds (Medzhitov, 2001). Ligand-binding results in 
internalisation of the ligand-receptor complex, activation of the cell, and the mounting 
of an inflammatory defensive response via activation of various transcription factors, 
most notably NF-κB.  
 
Cellular components of the innate immune system are already assembled in the intima 
of arteries in children at certain branching points, known to be possible sites for later 
development of atherosclerotic lesions. When the rolling, adhesion, and 
transendothelial migration of leucocytes is prevented, by lack of expression of either 
adhesion molecules or chemotactic molecules, atherosclerotic lesions are greatly 
reduced or do not develop. Therefore, atherosclerosis develops only to a minor extent 
in hypercholesterolemic mice deficient in VCAM-1(Cybulsky 2001), deficient in  P-
selectin (Johnson RC. 1997)  or deficient in  ICAM-I (Collins, 2000). MCP-1 is 
essential for the recruitment of monocytes into the intima. MCP-1/Apo-E or LDL-R 
double knockout mice do not develop atherosclerosis (Gu, 1998). Also, crosses of 
Apo-E^sup -/-^ or LDL-R^sup -/-^ mice with mice deficient in CCR-2 (the receptor 
for MCP-1) exhibit significantly impaired development of atherosclerotic lesions 
(Dawson, 1999).  Additionally, oxLDL deposited in intima acts as a monocyte 
chemoattractant, and oxLDL phospholipid constituents stimulate MCP-1 expression 
by endothelial cells (Cushing 1990). 
 
Arterial intimal macrophages derived from blood-borne monocytes exert both 
phagocytic functions (via their scavenger receptors) and innate defence functions (via 
other PPARs). The main representatives of scavenger receptors are CD36, SR-P1, and 
SR-A. These receptors bind oxLDL and, as they are not saturable, result in the 
formation of foam cells. Phagocytosis in general, and activation of macrophages via 
TLRs in particular, lead to the generation of reactive oxygen species - a major 
microbial killer mechanism - and thus transduction of inflammatory signals. An 
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additional role for TLRs as target-presenting structures, is to interact with CD14, the 
non-transmembrane receptor for LPS, involved in the induction of inflammatory 
reactions (Chen 1999). 
 
Humoral components of the innate immune system include natural antibodies, 
complement components, acute-phase proteins such as C-reactive protein (CRP), 
matrix-metalloproteinases (MMPs), and their antagonists (tissue inhibitors of 
metalloproteinases (TIMPs). Deposits of complement components as a result of 
activation - via the classical, the alternative, or the mannose-dependent pathways - are 
known to be present within atherosclerotic lesions and may represent a transitional 
mechanism between innate and adaptive immunity in atherogenesis (Seifert 1988). 
 
In summary, there is a large body of literature demonstrating a major role for 
involvement of cellular and humoral components of the innate immune system in the 
development and progression of atheromatous lesions.  
 
1.3.1.2  The role of the adaptive immune system in the development of 
atherosclerosis 
 
Complement activation occurs in the arterial intima of rabbits shortly after 
beginning a cholesterol-rich diet (Seifert 1988, 1989, Vlaicu, 1985). Complement 
activation via the classical pathway could be the result of the deposition of immune 
complexes in the arterial intima, or it may reflect the binding of specific antibodies to 
autologous or exogenous antigens localised in the arterial wall. The former include 
oxLDL and HSP60, whereas the latter comprise various types of micro-organisms 
such as EBV, CMV, or bacteria such as Chlamydia. Cholesterol crystals and other 
lipid components have been shown to activate this pathway in vitro (Ishida 2001). 
That intralesional complement is activated by the classical pathway is supported by its 
co-distribution with IgG, although the specificity of such locally deposited antibodies 
has not yet been demonstrated. Infection has an aggravating effect on atherogenesis, 
which could be due to the endothelial damaging effect of circulating immune 
complexes (Minick, 1973). 
 
                                                                                                                     Chapter 1 
 27 
Applying RT-PCR technology, Stemme (1991) showed that T cells in human 
atherosclerotic plaques are of polyclonal origin, suggesting that they are either 
recruited to the plaque in an activated stage or activated locally by mechanisms that 
do not lead to clonal proliferation. Nevertheless, the possibility that these populations 
contain pathogenic clones with locally relevant antigenic specificity cannot be ruled 
out. Oligoclonal T cell proliferation has been demonstrated in atherosclerotic lesions 
of ApoE^sup -/-^ mice (Paulsson, 2000). Knockout mouse models for cholesterol-
induced atherosclerosis have contributed considerably to the understanding of 
atherogenesis. It has to be emphasized, however, that these models do not reflect 
those situations in common human atherosclerosis that are induced by a variety of risk 
factors. Murine knockout models, such as LDL-R and ApoE knockout mice, in 
essence have their counterparts in genetically determined familial 
hypocholesterolemia in human patients. 
 
In common atherosclerotic lesions, Th1 cells expressing the cytokines IFN-γ and IL-2 
prevail over IL-4-, IL-5-, and IL-10-producing Th2 cells (Pinderski 2002, Hubber 
2001). This is reflected in significantly elevated serum levels of neopterin, an IFN-γ 
induced macrophage product (Xu, 1994). IFN-γ has a pro-inflammatory and thus pro-
atherogenic effect. This Th 1 cell product locally activates macrophages and inhibits 
SMC proliferation and collagen synthesis, leading to a higher risk of plaque instability 
and rupture. The pro-inflammatory effect of IFN-y is augmented by the macrophage-
derived cytokines IL-1 and TNF-α, and is reflected in the induction of expression of 
acute-phase proteins such as IL-6 and CRP in the liver (Teramoto, 2003). The anti-
inflammatory cytokine TGF-β produced by macrophages, SMC, and Th3 cells, has a 
pro-fibrotic effect, and thus promotes plaque stability. Blocking TGF-β signalling by 
appropriate monoclonal antibodies results in the development of larger and more 
unstable lesions. 
 
Although there are no definitive data on the route of migration of mononuclear cells 
to the vascular associated lymphoid tissue (VALT) area, or the specificity of the 
involved T cells, indirect evidence based on the distribution of certain adhesion 
molecules on endothelial cells and the composition of extracellular matrix (ECM) 
molecules provides some clues.  
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A basic expression of ICAM-1 and P-selectin by endothelial cells in the VALT area 
of normal carotid arteries has been found. ELAM-1 was not found on endothelial cells 
in any of the specimens investigated, explaining the lack of neutrophils that are 
known to adhere preferentially via this adhesion molecule. VCAM-1, expressed by 
both endothelial cells and macrophages within the VALT, may be instrumental in 
further recruitment of mononuclear cells and subsequent development of 
atheromatous lesions. Various stress factors, notably the classical atherosclerosis risk 
factors, can simultaneously induce expression of HSP60 and upregulation of adhesion 
molecules ICAM-1, VCAM-1, and ELAM-1 (Amberger, 1997). 
 
The ECM molecules, together with  cytokines and growth factors, contribute to the 
microenvironment of any tissue, including arteries. Cells of the immune system 
interact with ECM resulting in promotion or inhibition of their migration and 
function. They support cellular migration, e.g., collagen triple helices acting as 
conveyer belts for the movement of DC, whereas T cells show a similar pattern of 
migration depending on the three-dimensional structure of the ECM environment, 
e.g., via collagen-binding sites of VLA-1 and VLA-2. Ligand binding to these 
receptors induces T cell stimulation, resulting in the synthesis of cytokines and 
increased migration. 
 
 
1.3.1.3  Endothelial cell dysfunction in causation of atheromatous lesions 
 
Premature and accelerated vascular disease or ‘atheroma’ is an end stage 
vascular pathology with a complex pathophysiological structure. Amongst other 
changes, vascular disease in diabetic subjects is associated with abnormal peripheral 
blood monocyte function, abnormal function of the blood vessel lining cells and a 
marked infiltration around these blood vessels by fat-filled foamy macrophages 
(Schwartz, 1991). The endothelium is not just  a cell monolayer covering the luminal 
surface  of blood vessels, but a critical “structure” involved in inhibition of platelet 
adhesion, with many regulatory functions, such as the control of vascular tone, 
leucocyte rolling and transendothelial migration, and vascular smooth muscle cell  
growth and migration (Hsueh, 2003) (Issemann, 1990). 
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An increased frequency of apoptosis has been implicated as a hallmark of endothelial 
dysfunction (Isner, 1995) (Rossing, 2001) and has been documented in the vascular 
endothelium of diabetic animals and humans (Mizutani, 1996). Endothelium-derived 
nitric oxide (NO) plays an important role as an anti-inflammatory factor, because of 
its ability to reduce the expression of leucocyte adhesion molecules such as 
intercellular adhesion molecule (ICAM-1) and other inflammatory chemotactic agents 
like monocyte chemotactic protein (MCP-1), which is involved in migration of 
monocytes to the intima at the site of plaque formation (Localzo, 2001). A loss of  
endothelium-derived NO enhances the action of the pro-inflammatory transcription 
factor  NFkB,  resulting in increased expression of monocyte adhesion molecules and 
increased production of chemokines and  cytokines. These changes encourage 
monocyte migration into the intima and the formation of macrophage foam cells, 
changes characteristic of early atheroma (Creager, 2003) (Dosquet 1992) 
 
Even a small defect in endothelial function can have significant clinical implications 
(Landmesser, 2004). Beyond the impairment of endothelium-dependent vasomotion, 
endothelial dysfunction promotes key aspects of the atherosclerotic disease process, ie, 
vascular inflammation and thrombosis that are relevant at all stages of the disease. 
Conversely, a systemic inflammatory response that may involve detrimental effects of 
C-reactive protein on the endothelium augments endothelial dysfunction (Yeh ETH, 
2003).  
 
The observation that endothelial dysfunction represents an independent predictor of 
CV events suggests that assessment of endothelial function integrates variables 
beyond conventional risk factors, variables that may include the "pathogen burden” 
(Prassad, 2003), the genetic predisposition, and other not-yet-identified factors 
causing endothelial activation.  Increased vascular production of reactive oxygen 
species is characteristic of all major conditions predisposing to atherosclerosis (Cai H, 
2000), since bioavailability of NO reflects a balance between its production  via 
endothelial nitric oxide synthase (eNOS) and degradation  by superoxide oxygen 
derived free radicals (Costentino, 1997) (McVeigh GE, 1992). The molecular 
pathways leading to endothelial dysfunction-related events include: activation of 
protein kinase C and the transcriptional messenger NFkB with subsequent expression 
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of endothelial cell surface adhesion molecules, as well as increased expression of 
enzymes that promote oxidative stress (Gonzalez, 2003).  
Generally, in diabetic patients, hyperglycemia decreases endothelium derived NO 
(Tesfamarian, 1991) and activates PKC (Beckman, 2001), whereas excess free fatty 
acid liberation injures the endothelium via activation of PKC, and exacerbation of 
dyslipidemia (Dichtl, 1999) (Dresner, 1999) and insulin resistance mediate abnormal 
endothelial cell function by affecting the synthesis or degradation of NO (King, 
1996). 
 
1.4  Diabetes Mellitus 
 
1.4.1  Introduction 
 
Diabetes mellitus represents a group of diseases of heterogenous aetiology, 
characterised by chronic hyperglycemia and other metabolic abnormalities, related to 
deficiency of insulin. After long term metabolic instability, particular complications 
of diabetes may occur such as neuropathy, nephropathy, retinopathy, cardiovascular 
disease.(Kosaka, 1994). The deficiency of insulin action leads to characteristic 
abnormalities in the metabolism of carbohydrate, lipid and protein. If the metabolic 
abnormality is mild, patients may be asymptomatic, while in the presence of overt 
hyperglycemia, specific symptoms such as thirst, polydipsia, and polyuria and weight 
loss often occur. In severe cases, ketoacidosis may occur, that leads to disturbance of 
consciousness, coma and even death without treatment. With long duration of 
diabetes, small vessel abnormalities will ensue (microvascular disease), that leads to 
serious complications such as renal failure and blindness. Also diabetes accelerates 
the development of atherosclerosis, increasing the risks for occlusive artery disease 
(macrovascular disease) involving the lower limbs, the cerebral and coronary 
circulations. (Kawasaki, 1996) 
 
1.4.2  Classification of diabetes mellitus 
 
Both aetiological classification and staging of pathophysiology by the degree of 
deficiency of insulin effect need to be considered: 
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• Aetiological classification: 
 
1. Type I diabetes (T1DM), also known as insulin-dependent or juvenile-
onset diabetes is characterised by destructive lesions of pancreatic Beta 
cells usually by an autoimmune mechanism. This type of diabetes 
accounts for 10 to 15% of all cases of DM. Auto antibodies to islet cell 
antigens are detected in the majority of patients (70%-90%). Typically 
it occurs in young patients with acute onset but may occur at any age 
(Kobayashi, 1994). In the future, T1DM may be further divided into 
subtypes according to the mode of onset (i.e. acute or slowly 
progression), HLA antigens, or epitopes of autoantigens ((Imagawa, 
2000) 
 
2. Type II diabetes mellitus is characterised by a variable combination of 
decreased insulin secretion  and decreased insulin sensitivity. The mass 
of pancreatic Beta cells and their function are preserved to some 
extent. The majority of patients are obese or have been obese in the 
past. This type of diabetes classically develops after middle age, but 
may occur in younger people, particularly if they are obese (Kitagawa, 
1994, 1998) 
 
3. Gestational diabetes mellitus:  GDM is a state of glucose intolerance 
occurring for the first time during pregnancy, where relative insulin 
resistance is common. This glucose intolerance may affect the infant 
and mother adversely. Glucose intolerance during pregnancy is often 
normalised after delivery, but affected subjects have an increased risk 
of developing diabetes in the future (Kuzuya, 2002) (Knock, 1997) 
 
• Diabetes stage classification 
1. Non insulin requiring 
2. Insulin required for glycemic control 
3. Insulin dependent for survival (Kuzuya,2002) 
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1.4.3   Diagnosis of diabetes mellitus 
 
The confirmation of chronic hyperglycemia is a prerequisite for diagnosis, and 
in order to confirm persistent hyperglycemia, at least two plasma glucose 
measurements on separate days are necessary. Diabetes can be diagnosed following a 
single plasma glucose measurement with other metabolic abnormalities such as a high 
HbA1c level. (Kuzuya, 2002). T1DM is confirmed by a history of diabetic 
ketoacidosis and /or the presence of anti glutamic acid decarboxylase (GAD) 
antibodies. 
 
Criteria                                       Normal range                                Diabetic range 
Fasting plasma glucose                < 6.1                                                   ≥ 7.8  
2h postural glucose load               < 8                                                     ≥ 11.1 
 
Table 1.1:  Criteria for diagnosis of diabetes mellitus 
( Report of a WHO consultation. Diabet Med 1998; 15: 539-553)     
 
1.4.4       Vascular disease in diabetes 
 
1.4.4.1     Classification of vascular disease 
Macrovascular disease, or atherosclerosis, is the basis of more than half of all 
mortality in developed countries. It is a progressive disease of the large- and medium-
sized arteries. The name is derived from the Greek athero meaning "gruel" or "paste" 
and sclerosis meaning "hardening." Thus, atherosclerosis is the hardening of the 
arteries due to the accumulation of this paste (commonly called plaque).  
There are three principal sites of macrovascular disease: coronary artery, 
cerebrovascular, and peripheral vascular. 
Microvascular disease describes the thickening of the basement membrane seen in 
capillaries (LoGerfo and Coffman, 1984), and arterioles (Silhi, 1998) of diabetic 
patients. Thickening of the basement membrane is thought to be a result of the 
proliferative response of the vascular endothelium to chronic injury (Silhi, 1998), 
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brought on by the effects of hyperglycaemia on glucose metabolism, protein synthesis 
and non-enzymatic glycation of cellular and extracellular components.  
The accumulation of sorbitol in the cells due to defective glucose metabolism (Frank, 
1994) leads to increased oedema (Watkins et al, 1997), resulting in modified 
membrane function and permeability. Alterations in basement membrane protein 
synthesis and advanced glycation end products (AGEs) formed as a result of 
nonenzymatic glycation lead to functional changes of the microcirculation, causing a 
reduced ionic charge, allowing albumen across the basement membrane and leading 
to altered cellular nutrition (Stonebridge, 1996).   
1.4.4.2  Incidence and predispositions of vascular disease in diabetes 
 
Macrovascular disease accounts for more than 70% of deaths in people with 
diabetes, mostly from myocardial infarction, congestive cardiac failure and stroke. 
Risk factors for the development of macrovascular disease in diabetes include age, 
race, cigarette smoking, hypertension, raised cholesterol, HbA1c levels, and obesity. 
There is little support for the suggestion that the macrovascular disease of diabetes is 
histologically or biochemically different from atherosclerosis in the non-diabetic 
individual, but there may be some differences in the extent and distribution of disease 
Diabetic macrovascular disease manifests in the form of atherosclerotic heart disease, 
peripheral vascular disease, and cerebrovascular disease. The increased risk of 
macrovascular disease in diabetes mellitus can be attributed to a higher prevalence of 
predictable risk factors, many of which are part of the insulin resistance syndrome. 
More "controversial" risk factors, i.e., triglycerides, plasma glucose, and insulin, are 
uncertain.  
In type 2 diabetes, hypertriglyceridemia has long been associated with an increased 
risk of macrovascular disease (Fontbonne, 1989).  Whether hypertriglyceridemia is 
the connection between increased plasminogen activator inhibitor 1, decreased HDL 
cholesterol, and/or small dense LDL or is independent of these expected relationships 
is unclear. Almost all patients with hypertriglyceridemia >200 mg/dl have small dense 
LDL (Austin, 1990) but only some are at increased risk of macrovascular disease. 
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Hyperglycemia has been observed as a cause of vascular diseases in animal models 
and also the ‘Diabetes Control and Complications’ trial demonstrated that aggressive 
glycaemic control in type I diabetes reduces significantly the risk of microvascular 
complications, such as retinopathy and nephropathy. A link between hyperglycaemia 
and macrovascular disease was shown in the San Antonio Heart Study that revealed a 
high proportion of cardiovascular related deaths in those with higher fasting blood 
glucose levels NIDDM (Wei, 1998).  
The ‘Wisconsin Epidemiologic Study of Diabetic Retinopathy’ revealed that an 18% 
increase in cardiovascular mortality was associated with a 1 % increase in glycated 
hemoglobin (Klein, 1995). Despres has shown that hyperinsulinaemia and insulin 
resistance accelerate the development of atherosclerosis (Despres, 1996), and another 
study of multiple ethnic groups have shown increased carotid intimal and medial 
thickness (a reliable marker for coronary disease) in subjects with insulin resistance 
(Howard,1996). The presence of hypertension in diabetic patients increases 
significantly their risks of both microvascular and macrovascular disease. Several 
studies have demonstrated a benefit of blood pressure control in reducing these 
complications  (Estacio, 1998), (Prospective Diabetes Study Group,1998) 
 
1.5  Diabetes and the immune system in pregnancy 
 
1.5.1  Diabetes actively affects pregnancy 
 
Pregnant women with type I diabetes have a particularly high level of risk for 
the development of atheromatous lesions, and the placenta is a specific target organ. 
The precise mechanisms regulating the initiation and progression of vascular lesions 
in diabetic pregnant women are unclear. There is evidence that atypical cellular 
immunity is central to the development of this abnormal atheroma-like lesion within 
maternal intrauterine blood vessels supplying the placenta in type I diabetic pregnant 
women over a very short space of time. Saviddu has demonstrated that in pregnant 
women with Type 1 diabetes, vascular function during the second trimester and late 
pregnancy is significantly impaired compared with normal healthy pregnant women 
(Saviddu, 2002), and that this impairment may result from decreased production of 
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endothelium-derived nitric oxide as a result of reduced nitric oxide synthase activity 
or decreased availability of L- arginine (Tesfamariam, 1993) ( Sobrevia, 1994). 
Pregnancies in women with pre-existing T1DM mellitus are complicated by 
considerably higher than normal rates of severe perinatal complications, and women 
with poor self-care are at the highest risk.  The problems are well demonstrated in a 
report from Dorte (2004), summarised in Table 1.5.1.1 below. The perinatal mortality 
rate was 3.1% in T1DM pregnancies compared with 0.75% in the background 
population (RR 4.1 [95% CI 2.9–5.6]), while the stillbirth rate was 2.1% compared 
with 0.45 (RR 4.7 [3.2–7.0]). The congenital malformation rate was 5.0% in the study 
population and 2.8% (1.7 [1.3–2.2]) in the background population. Six of the perinatal 
deaths (16%) were related to congenital malformations. Only 34% of women 
performed daily home monitoring of blood glucose at conception, and 58% received 
preconceptional guidance.  
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                                                                 T1DM              Normal              Relative risks 
                                                                                                                      P value  
n 1,215 70,089  
Pre-eclampsia* 220 (18.1%) * 1822 (2.6%) <0.001 
Caesarean section 680 (55.9%) 8,831 (12.6%) 4.4 (4.1–4.8) 
Preterm delivery  507 (41.7%) 4,205 (6.0%) 7.0 (6.3–7.6) 
Gestational age at delivery (days) 256 ± 16 280+ 15 <0.0001 
Birth weight (g) 3,487 ± 817 3,478+ 816 0.71 
Birth weight 4,500 g 97 (8.0%) 2,383 (3.4%) 2.3 (1.9–2.9) 
Large for gestational age infant  761 (62.5%) — <0.001 
Stillbirth 26 (2.1%) 318 (0.45%) 4.7 (3.2–7.0) 
Perinatal mortality 38 (3.1%) 525 (0.75%) 4.1 (2.9–5.6) 
Congenital malformations 61 (5.0%) 1,987 (2.8%) 1.7 (1.3–2.2) 
Respiratory distress syndrome  202 (17.1%)         ND — 
Jaundice 215 ( 18.1%)           ND           — 
 
Table 1.2 : Obstetric complications and fetal characteristics for type 1 diabetic 
pregnancies and the background population (Dorte, 2004). 
 
Data are mean ± SD or n (%). * Blood pressure 140/90 mmHg and proteinuria. The 
frequency in the background population is 2.6% before 37 completed weeks of 
gestation; birth weight 90th centile. The expected frequency in the background 
population is 10%, but exact numbers are not available; use of continuous positive 
airway pressure for >1 h postpartum;   
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Pregnancies with serious adverse outcomes (perinatal death and/or congenital 
malformations) were characterised by higher HbA1c values before and during 
pregnancy and a lesser degree of maternal self-care and preconceptional guidance. 
Women who performed daily self-monitoring of blood glucose at any time during 
pregnancy had lower HbA1c values than women who did not measure their daily 
profile. Likewise, daily self-monitoring was associated with a reduction in serious 
adverse outcomes. The caesarean section rate was 55.9% in diabetics and 12.6% in 
normal women, while the risk of preterm delivery was 41.7% and 6.0%, respectively. 
These results are consistent across several publications (Casson 1997, Howthorne 
1994, Suhonen 2000, Penney 2003, Boulot 2003, Westergaard 1997, Miller, 1981), 
and others shown in Table 1.3 below. 
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                                                      Serious adverse outcomes      others    Relative  risks 
                                                                                                                              P value                      
n 93 1,125  
Age (years) 28 (25–31) 29 (26–32) 0.49 
Preconceptional BMI (kg/m2) 22.1(19.424.2) 23.0 (21.4–25.3) 0.01 
Diabetes duration (years) 12 (6–18) 12 (5–19) 0.75 
Daily blood glucose monitoring at conception 18 (22.5%) 363 (34.6%) 0.019 
Preconceptional guidance 38 (42.7%) 631 (59.2%) 0.002 
HbA1c 0–3 months prior to conception (%) 8.0 (7.3–9.1) 7.6 (6.8–8.5) 0.005 
HbA1c during first trimester (%) 7.6 (6.6–8.6) 7.3 (6.6–8.1) 0.037 
HbA1c during second trimester (%) 6.9 (6.2–8.0) 6.6 (6.0–7.3) 0.012 
HbA1c during third trimester (%) 7.1 (6.5–7.9) 6.7 (6.2–7.4) <0.001 
Retinopathy* 5 (5.8%) 78 (7.3%) 0.58 
Nephropathy  8 (9.0%) 70 (6.4%) 0.34 
Hypertension  6 (6.7%) 53 (4.8%) 0.45 
Pre-eclampsia  15 (18.1%) 205 (18.1%) 1.0 
Large for gestational age infant|| 48 (57.1%) 713 (62.9%) 0.30 
 
Table 1.3: Maternal characteristics in pregnancies with serious adverse outcomes 
(perinatal death and/or congenital malformations) versus other pregnancies. (Neilsen 
2004, Evers 2002, Hanson 1990). 
Data are median (interquartile range) or n (%).  * Proliferative retinopathy; 
nephropathy (urine albumin excretion >300 mg/24 h or >200 µg/min); hypertension 
(pharmacological treatment) before pregnancy and/or during first trimester; blood 
pressure 140/90 mmHg and proteinuria; | birth weight 90th centile.  
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1.5.2   Significant changes in the function of the immune system are necessary for  
            successful pregnancy 
 
The ‘immunological irony’ of pregnancy refers to the observation that fetal 
development proceeds unimpaired despite the fact that the fetus is an allograft 
(Bonney, 1997), ( Munn, 1998),  and an adaptation of the maternal immune system is 
clearly necessary to prevent rejection of the fetal allograft (Weinberg, 1984), 
(Vacchio, 1999). Some studies have described normal pregnancy as characterized by 
an activation of circulating leucocytes as part of a generalized immune response 
(Faas, 2000), (Sacks1998), and because of the role of adhesion molecules in 
mediating leucocyte responses to inflammatory stimuli and cell- cell or cell-matrix 
interactions, it is likely that there are changes in the expression of adhesion molecules 
present on resting leucocytes or in mobilization of adhesion molecules to the surface 
of monocytes. 
 
Several investigations have showed contradictory results about changes in the 
different subsets of maternal peripheral blood leucocytes. In normal human pregnancy 
for example, Tallon has reported a decrease in CD8 T cells, (Tallon, 1984), whereas 
other investigators have described an increase (Fiddes, 1986) (Rich,1999). Some 
authors have found that T lymphocytes from pregnant women have impaired 
functional activity, and reduced levels of production of inflammatory cytokines 
(Weinberg, 1984), (Matthiesen, 1995), and reduced levels of production of 
inflammatory cytokines (Cracker, 2005). 
The innate immune system is activated during pregnancy. Monocytes and 
granulocytes from pregnant women show increased surface expression of activation 
markers and adhesion molecules (Sacks, 2000). They show increased production of 
intracellular reactive oxygen species and enhanced phagocytosis compared with the 
nonpregnant state. Granulocytes from pregnant women have reduced microbial killing 
activity and chemotaxis as well as a decreased respiratory burst activity (Maallem, 
1980) (Bjorksten, 1978). Luppi and his colleagues have found, in normal pregnancy, 
an increase in the proportion of granulocytes, a decrease in the level of  monocytes, 
but no change in the percentage of distribution of CD3+ T cells and CD 19+ B cells, 
CD14+ monocytes and CD 56+ natural killer cells in  pregnancy,  compared with the 
non pregnant state (Luppi, 2002).  
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The same group has reported that CD+4 T lymphocytes decreased, while of CD8+ T 
lymphocytes increased, the percentage of granulocytes (CD15+) that positively 
stained for CD11a and CD454 was significantly higher in pregnant women than in the 
nonpregnant control group, also there was a significant increase in the level of 
monocyte expression of CD 62L, which is important for the initial attachment of 
circulating monocytes to activated endothelial cells (Von Anderian, 1991). 
Granulocytes from normal pregnancies showed a significantly higher surface 
expression of CD11a and CD11b compared with the non pregnant group, whereas 
monocytes showed higher surface expression of CD11a, CD11b, CD54, CD49d and 
CD62L in normal pregnancy compared with the non pregnant group (Luppi, 2002). 
 
1.5.3 Interaction of diabetes, the immune system and pregnancy 
 
Pregnancy is a very real immunological and metabolic challenge, and the 
interplay of pre-existing maternal diabetes, also challenging to the same aspects of 
physiology, carries a number of potential risks and difficulties in adaptation.  In 
addition to possible effects on general maternal vascular and immune function, 
abnormal function of cells of the immune system, common in diabetes, may have 
specific deleterious effects on the development of the vascular bed at the maternal 
fetal interface. Within the placental bed, despite direct contact between 
immunologically disparate cells of maternal and feto-placental origin, there is usually 
no apparent reaction between them. In contrast, women with T1DM who become 
pregnant have an increased incidence of atherosis, the atheromatous-like lesion seen 
in their placental bed blood vessels, a lesion associated with reduced feto-placental 
blood flow resultant fetal compromise. This lesion involves the ingress of maternal 
monocytes/macrophages, as does atheroma in other vascular beds in the non-pregnant. 
The mechanisms subserving this placental bed pathology have not yet been 
investigated. Given the pathophysiological events that precede the development of 
atheroma in other vascular beds in the non-pregnant, it is likely that it involves 
increased adhesion of circulating monocytes to the endothelial cells of the decidual 
microvasculature. The work described in this thesis is therefore directed at further 
understanding of the regulation of this process. 
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Summary 
 
In this chapter, I have described some of the relevant background linking immunity, 
atheroma, diabetes and human pregnancy. I have identified a set of adhesion 
molecules that are likely to mediate increased monocyte adhesion to the decidual 
endothelium in type I diabetic pregnant women.  
  
Hypothesis to be tested 
 
The current study investigates the hypothesis that monocytes from type I diabetic 
pregnancy, compared with normally pregnant women,  express higher levels of 
specific adhesion molecules, and that these molecules play an important role in 
peripheral blood monocyte adhesion to the endothelial cells of the decidual 
vasculature. 
 
Specific Aims 
 
• To compare the level of expression of  the adhesion molecules LFA1, VLA4 
and MAC1 in peripheral blood monocytes from normal pregnant women and 
pregnant women with Type 1 diabetes mellitus    
 
• Using specific function-perturbing antibodies, to examine aspects of the 
regulation of monocytes adhesion molecule expression in pregnancy, and the 
effects of this on monocytes adhesion to decidual endothelium. 
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2.     Introduction  
 
This chapter outlines general procedures for cell isolation and maintenance, 
and cell culture and co culture techniques used in this project. Specific methods 
related to individual experiments are described in relevant chapters.  
2.1     
Subjects involved in the study were women attending Royal North Shore 
Hospital and North Shore Private Hospital for antenatal care between 2004 and 2006. 
The project was approved by the Human Research Ethics Committees of both 
hospitals. All subjects gave written informed consent. All subjects were in the third 
trimester of pregnancy. Women with known medical disorders other than diabetes or 
with fetal abnormalities were excluded from study. Women in labour at the time of 
delivery, or with ruptured membranes prior to caesarean section were excluded from 
study.  
 
2.1.1   Normal pregnant women 
Subject selection 
Healthy pregnant women were selected on the basis of a normal medical 
history and physical and laboratory examination. A woman was considered normal 
after having, at 26-28 weeks gestation, either negative screening results for gestational 
diabetes or negative OGTT (oral glucose tolerance test).  
 
2.1.2  Pregnant women with Type I diabetes mellitus (T1DM) 
 
These were women known to have T1DM pre-pregnancy, confirmed by a 
history of diabetic ketoacidosis and /or the presence of anti glutamic acid 
decarboxylase (GAD antibodies). 
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2.1.3     Pregnant women with gestational diabetes
Pregnant women were considered to have gestational diabetes after having a 
positive screening test for gestational diabetes (50g glucose challenge, 1h blood sugar 
>7.8mmol/L), performed at 26-28 weeks gestation and a positive 75g oral glucose 
tolerance test (fasting venous plasma glucose > 5.5 mmol/l, and/or > 8.0 mmol/l after 
2 hours). (AOA criteria) 
                                          
2.2     Cell isolation 
2.2.1      Serum/cell preparation from blood  
2.2.1.1    Collection of whole blood for pooled maternal serum (PMS)  
   
Whole blood was collected from normal women in the second trimester of 
pregnancy (approximately 60 ml in total weekly from 4-6 volunteers) into tubes with 
a clot activator for serum. This blood was centrifuged immediately (2000g, 15 min), 
then the serum was transferred to a sterile 50 ml tube and stored at –200
2.2.1.2     Collection of whole blood for peripheral blood monocyte isolation  
C for later 
preparation of culture medium (which contained 40 %  pooled maternal serum) 
 
 
For isolation of monocytes, 40 ml of venous blood was drawn aseptically via a 
vacutainer device into tubes containing disodium ethylene diamine tetra-acetic acid 
(EDTA) (final concentration 5.5mmol/l).  
.                    
2.2.2   Monocyte isolation 
 
Density gradient centrifugation has been validated in our laboratory and was 
chosen as the method for isolating monocytes in my study (Nutt et al 2004).  The 
monocytes in human peripheral blood account for an average of 8% of the leucocyte 
population. They are larger (15-20 μm) than lymphocytes (6-20 μm) and they have 
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slightly lower density. These characteristics allow their separation on the basis of 
flotation from human leucocyte-rich plasma (LRP).  
 
2.2.2.1   Monocyte isolation procedure 
 
Blood was centrifuged at 2000 g for 5 minutes at room temperature. The upper 
plasma layer was removed and the buffy coat (leukocyte-rich plasma (LRP)) was 
collected. More than 90% of the leucocytes were recovered in this manner, with a 
small number of contaminating erythrocytes. 
 
Two density solutions were produced by mixing a 60% solution of iodixanol 
(OptiPrep (Axis-Shield PoC AS-Denmark)) with a medium comprising RPMI 1640 
plus 10% fetal calf serum (endotoxin free). 
 
Density solutions of 1.084 g/ml (1.5ml of the 60% OptiPrep with 4.5 ml of medium) 
and 1.065 g/ml (3 ml of the 60% OptiPrep with 13.4 ml of medium) were prepared. 
One volume of LRP was mixed with 0.4 volumes of OptiPrep. Approximately 2 ml of 
the LRP/ OptiPrep mixture was loaded into each of two 15 ml polypropylene 
centrifuge tubes, then overlaid successively with 2 ml of the 1.084 g/ml density 
solution, 4 ml of the 1.065 g/ml, and then a layer of medium (0.5 ml) on top. (While 
this layer is not required for the separation process, it minimises the banding of cells 
at a liquid/air interface, and also inhibits cell adhesion to the walls of the tube). 
 
Then the tubes were centrifuged at 2000 g for 15 minutes in a swinging bucket rotor 
centrifuge without application of the brake during the phase of deceleration. The layer 
below the upper interface (i.e. the layer which contained the monocytes that had 
floated into the 1.065 g/ml layer) was collected. The resultant cell suspension was 
diluted with medium and the cells counted in a Fuchs-Rosenthal counting chamber. 
The cell suspension was then centrifuged at 1000 g  for 5 minutes, and the resultant 
pellet resuspended in 2% FCS+ M199- at a concentration of 105 cells per ml. 
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2.2.2.2  Assessment of cell yield 
 
The yield of recovered monocytes was calculated by counting the cells and 
comparing the numbers with a monocyte count performed on whole blood at the same 
time by the hospital pathology department. 
 
2.2.2.3   Preparation of cytospins 
 
Cytospins were arranged from the cell suspensions for consecutive 
immunostaining. Cells from each isolation were adhered to glass microscope slides in 
a cytocentrifuge (Cytophonel). The sample chambers and slides were assembled, then 
loaded with 200 µl cell suspension and centrifuged at 1000 revolutions per minutes 
(rpm) for 5 minutes.  
The slides were allowed to dry overnight at room temperature. The cytospins were 
immunostained the next day or wrapped in aluminium foil and stored at -200C for 
later staining. 
 
2.2.2.4    Immunolabelling of monocytes 
 
Cytospins were fixed in 50% (v/v) acetone/ 50% (vol/vol) methanol for 2 
minutes, and then washed twice in wash buffer (0.15 M sodium chloride (TBS) with 
0.1 % (wt/vol) bovine serum albumin (BSA) and 0.1 % (v/v) Tween-20) for 5 min. 
The area surrounding the sample was blot dried and the cytospins encircled with a 
PAP pen. Samples were covered with wash buffer for 5 minutes then incubated in 
blocking solution (DAKO) to block non-specific binding; they were then washed 
again in wash buffer for 5 minutes.  
The primary antibody and control antibodies were diluted and applied to samples for 
one hour at room temperature. 
Monocytes were identified with mouse anti human CD68 (clone EBM11, 1: 100 
dilution) and lymphocytes with mouse anti human CD3 (1:100) as control. After one 
hour incubation, samples were washed twice for 5 minutes in wash buffer and  a 
LSAB 2 kit provided the secondary antibody and the peroxidase amplification step: a 
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biotinylated goat anti mouse secondary antibody (reagent 1) was applied for 10 min 
preceding incubation with streptavidin conjugate (reagent 2) for an additional 10 min. 
 
The peroxidase substrate 3, 3 - diaminobenzidene (DAB) was applied for 
approximately 5 minutes to allow visualisation of the immunolabelling as a brown 
colour. Samples were then washed in water for 5 min, stained for 2 min in 
Haematoxylin (1:1) in water, and washed again in water for 5 min.  
 
 
 
Samples were covered with Glycergel and cover-slipped to be examined later under 
the microscope. CD68 positive cells were classified as monocytes, CD3 positive cells 
as lymphocytes. 
 
Figure 2.1: Monocytes isolated from peripheral blood by density gradient 
centrifugation. Population of >95% purity (Brown colour shows the immunostained 
CD68 positive cells, and the small number of lymphocytes are stained blue) 
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2.2.2.5 Assessment of cell purity 
 
The purity of the monocyte population isolated from each sample was 
determined in the immunostained cytospins, using the following formula: 
 
Percentage purity = (number of CD68 cells/ total cell count) x 100 
2.2.3     Peripheral blood mononuclear cell isolation  
Peripheral blood mononuclear cells (a mixture of lymphocytes and 
monocytes) (PBMCs) were isolated from whole blood using the density gradient 
medium Ficoll Paque Plus.  
 
2.2.3.1 PBMC isolation from whole blood using Ficoll-Paque  
 
Anticoagulated blood (24 ml, 12 ml per tube) was diluted 1:1 in Hanks 
balanced salt solution (HBSS), with added 2.214 mM sodium bicarbonate, 0.499mM 
disodium ethylenediaminetetraacetic acid (Na2EDTA), 100 U/ml benzyl penicillin 
and 100 μg/ml Streptomycin under strictly aseptic, endotoxin-free conditions, then 
gently layered over the Ficoll Paque in polypropylene 50 ml Falcon tubes, at a ratio 3 
ml of Ficoll Paque to 4 ml of diluted blood.  
These layered samples were then centrifuged with fast acceleration and slow 
deceleration at 1550 g for 40 min at 200 C in a Beckman Coulter Allegra 6R 
centrifuge (Beckman, USA). The plasma layer was discarded using a plastic transfer 
pipette. The buffy coat was collected from each tube with a sterile plastic transfer 
pipette into 50 ml sterile Falcon tubes and combined into one tube. Cells were washed 
twice in PBS and centrifuged  at 1550 g for 10 minutes at 200C. The resultant cell 
pellet was resuspended in a small volume of PBS, counted in a Neubauer 
haemocytometer.  
For counting, cells were diluted 1/20 with Turks White Cell count (1% 
Toluidine blue, 1% glacial acetic acid), that stains nuclei. 
The number of PBMCs in each of the four large squares of the counting chamber was 
counted and the average cell number was determined. 
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The following formula was used to determine the number of cells per ml of 
suspension:  
 
                       Cells /ml= number of cells counted x 20x10000 
 
Flowcytometry: 
 
PBMCs (105 /ml) were resuspended in PBS/0.1%BSA, washed twice, then placed in a 
1.5 ml eppendorf tube. PBMCs were pelleted by centrifugation at 14000 rpm for 20 
seconds at 200C in an Eppendorf centrifuge 5417 R. (Hamburg, Germany). Cells were 
resuspended in PBS/0.1/BSA (final volume 50uL), the appropriate conjugated 
antibody was added (5 μl/ 1ml), and the cells were incubated with the antibody for 40 
minutes at 40C. 
After 40 minutes the PBMCs were washed in 1 ml PBS/0.1/BSA and then centrifuged  
at 14000 rpm for 20 seconds, fixed in 250 μl 1% paraformaldehyde (PFA) in 
PBS/0.1/BSA and stored at 40
              
C until proceeding with flow cytometry 
 
 
 
 
Figure 2.2: Ficoll Paque plus density gradient medium 
A-Plasma layer, B-Buffy coat layer containing the PBMCs, C-Ficoll Paque layer 
separating Buffy coat from erythrocytes, and D- erythrocyte layer 
 
 
A 
B 
C 
D 
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2.3      Decidual endothelial cells (DEC) 
 
Endothelial cells were isolated from decidual biopsies by standard methods in 
our research group (Gallery et al 1991). This method utilises the ability of endothelial 
cells to bind selectively to the lectin Ulex europaeus I (UEA I).  
 
Decidual biopsies were collected from the interior surface of the uterus after delivery 
of the placenta by the obstetrician at elective caesarean section at Royal North Shore 
Hospital. The biopsy was immediately placed into a sterile plastic jar containing cold 
calcium- and magnesium-free Hanks’ balanced salt solution (HBSS) and kept at 4o
2.3.1 DEC isolation procedure 
C 
until processing. 
 
 
  Decidual biopsies were transferred into a 100 mm diameter Petri dish 
containing 10 mL of HBSS and sliced into 2-3 mm cubes using a scalpel blade. The 
tissue was then incubated at 37o
The pellet was resuspended in 80 µL of 5% FCS in HBSS and transferred to a 5 mL 
tube. UEA 1-coated polystyrene-coated magnetic beads (Dynabeads, coated anti-HLA 
C for 6-8 minutes in 0.12%  trypsin and 0.8% pronase 
in 10 mL of HBSS (corrected to pH 7.4 with sodium hydroxide), with gentle agitation 
every 2 minutes. The resultant fragments were washed in 10 mL of HBSS with gentle 
agitation to dilute the enzymes. 
  
The HBSS was poured off and after four further washes the tissue was transferred to a 
sterile Petri dish containing 10 mL of 5% FCS in HBSS. Pieces of tissue were then 
transferred independently to a sterile 100 mm diameter Petri dish containing 10 mL of 
HBSS. Using the flat edge of a scalpel blade, capillary segments were squeezed from 
the enzyme-digested edges of the tissue fragment by downward pressure. The 
resultant mixed cell population included endothelial cells, fibroblasts, and tissue 
fragments. The suspension was collected into a 15 mL tube and centrifuged at 1000 
rpm for 5 minutes.  
 
                                                                                                                         Chapter 2 
 51 
class I antibody, Dynal, Oslo, Norway) (20 µL) were added and the suspension 
incubated on a rotator for 10 minutes at 4oC. After incubation, 1 mL of 5% FCS in 
HBSS was added to the tube, mixed gently to resuspend cells and beads, and the 
suspension transferred to a 14 mL round-bottom polypropylene tube. This was 
repeated with another 1 mL of 5% FCS in HBSS to ensure that all contents were 
transferred. The tube was then attached to a magnetic particle concentrator for 1 
minute.  
 
Endothelial cells that had bound to the UEA I-coated Dynabeads were collected along 
the wall of the tube, and contaminating cells were tipped off into a second 15 mL 
centrifuge tube. This rinse procedure was repeated four times. Cells bound to the 
UEA I-coated beads were washed twice with 5 mL of 5% FCS in HBSS and 
transferred to a 15 mL centrifuge tube. Both tubes (one containing the purified 
endothelial cells and the other containing the non-endothelial mixed cell population 
that had been separated from the bead-containing cells) were centrifuged at 1000 g for 
5 minutes. Each cell pellet was resuspended in 100 µL of decidual endothelial cell 
growth medium containing 40% pooled human pregnancy serum. 
 
The cell suspensions were seeded into the centre of 35 mm diameter culture dishes 
that had been pre-coated for 5 minutes with 100 µL of gelatin 0.2%, and these dishes 
were placed into a 100 mm diameter Petri dish. Cells were incubated for at least 5 
hours or overnight in a humidified incubator at 37oC in a 95% air, 5% carbon dioxide 
atmosphere to allow cell attachment to the gelatin-coated plastic. The cells were then 
washed in HBSS to remove non-adherent cells, and fresh growth medium was added 
(2 mL/dish). Cells were grown at 37o
Endothelial cells were identified under a phase contrast microscope. They appeared as 
large polygonal cells with centrally located nuclei, forming a confluent homogeneous 
monolayer with a cobblestone appearance. In addition to their morphology, 
endothelial cells were positively identified by immunocytochemical staining for the 
C with replacement of growth medium every 
second day. The Dynabeads were slowly released from the endothelial cells with 
continued cell reproduction and removed from the culture dish with refeeding and 
subsequent passaging.  
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presence of Von Willebrand factor (vWF) antigen. Cells were purified by positive 
selection with lectin ulex europeus 1 (UEA1; Sigma, St. Louis, MO), giving 
2.3.1.1  Cell passaging 
a 
population of endothelial cells of >95% purity (determined visually). However, to 
achieve this, vigilant daily monitoring under a phase contrast microscope was 
required to identify and remove any contaminating cells, which were eliminated by 
mechanical weeding using a Pasteur pipette attached to a vacuum pump. This 
procedure was performed with the 35 mm diameter culture dish placed on the stage of 
a phase contrast microscope in the laminar flow hood. Contaminating cells were 
located under the microscope and aspirated with sharp, precise movements, taking 
care not to remove the surrounding endothelial cells nor allow the culture dish to dry 
out during the procedure.  
 
Decidual endothelial cells were passaged when they reached confluence, 
usually within 7-10 days of initial isolation. Passaging was performed using a solution 
of 0.01% (w/v) trypsin and 1 mM EDTA in HBSS (pH 7.4). The growth medium was 
removed from the culture dish and the cells washed with 3 mL of HBSS. 0.4 mL of 
HBSS was added plus an equal volume of the trypsin/EDTA solution, and the dish 
was incubated at 37oC for up to 10 minutes. Every 3 minutes the dish was gently 
agitated and examined under a phase contrast microscope. Once most of the cells had 
lifted from the dish, 1.5 mL of growth medium was added to terminate trypsin 
activity. The cells were resuspended and transferred into a fresh 35 mm culture dish 
precoated with gelatin. The cells were incubated for at least 5 hours or overnight at 
37oC, then were rinsed with HBSS and re-fed with 2 mL of growth medium. 
 
Once the 35 mm culture dish was confluent, the passaging practice was repeated and 
the cells were transferred into a gelatin-coated 80 cm2
 
 flask with an additional 8 mL 
of growth medium. The medium was replaced every second day until confluence (an 
average of four weeks after the initial decidua isolation).  
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Fig 2.3:  Isolated Decidual endothelial cells from normal pregnant women 
 
 
 
 
 
Decidual endothelial cells 
within 3 days of isolation,  
Confluent decidual 
endothelial cells, X 40  
 
Confluent decidual 
endothelial cells, X 100 
Decidual endothelial cells 
containing magnetic beads 
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2.3.1.2  Cell freezing and thawing 
 
Confluent cells at passage two were washed in 10 mL of HBSS, and then 
lifted from the flask using 2 mL of HBSS plus 2 mL of trypsin/EDTA solution. The 
suspended cells were centrifuged at 1000 g  for 5 minutes and the cell pellet 
resuspended in a cryogenic solution comprised of 100 µL dimethyl sulfoxide (DMSO) 
and 900 µL of growth medium or pooled maternal serum (M199+ + ECG + 40% 
PMS). The cell suspension was immediately transferred into a 1.8 mL cryotube, 
placed in a pre-cooled cryofreezing container and stored at –70oC overnight. The 
following day the cells were transferred to a liquid nitrogen tank. Cells were stored in 
liquid nitrogen until required for experiments. 
 
To recover cells from liquid nitrogen, the cryogenic tube was thawed quickly in a 
37oC water bath and the contents immediately transferred to a 15 mL centrifuge tube 
containing 10 mL of growth medium. The tube was centrifuged at 1000 g for 5 
minutes, the cell pellet resuspended in 8 mL of growth medium, and transferred to a 
gelatin-coated 80 cm2 flask. Decidual endothelial cells, examined by phase contrast 
microscopy, appeared as large polygonal cells with centrally located nuclei, forming a 
confluent homogeneous monolayer with a characteristic cobblestone appearance.  
 
 
2.3.1.3      Pooling of decidual endothelial cells, and preparation of aliquots for 
co-culture experiments 
 
Cells from ten decidual endothelial cell isolations were thawed and grown to 
confluence in 75 mm flasks, which had been pre-coated with gelatin. When the 
decidual endothelial cells were confluent, each flask was trypsinised, and the cells 
were divided between two coated flasks. All flasks were trypsinised when confluent, 
the decidual endothelial cells were pooled and 20 aliquots made and stored, as 
previously described, in liquid nitrogen. 
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Figure 2.4  This Figure shows a population of decidual endothelial cells positively 
selected with Ulex Europaeus-1-coated magnetic beads, pooled from 20 normal 
subjects at passage 2, prior to preparation and freezing of aliquots 
 
2.3.1.4      Preparation of UEA 1-coated dynabeads 
 
UEA I was covalently conjugated to Dynabeads M-450 (containing a ferrous 
core). The Dynabeads (4 x 108 beads/mL) were first washed in borate buffer (0.1 M, 
pH 8.5) for 5 minutes in a 5 mL tube, and then collected using a magnetic particle 
concentrator. The supernatant was discarded and the wash repeated. Equal volumes of 
UEA 1 (0.2 mg/mL in 0.1 M borate buffer, pH 8.5) and Dynabeads suspension (4 x 
108 beads/mL) were mixed on a rotator at 4oC for 24 hours. The beads were collected 
using a magnetic particle concentrator and the supernatant discarded. The beads were 
washed twice with 0.1% (w/v) bovine serum albumin (BSA) in 0.1 x calcium- and 
magnesium-free phosphate buffered saline (PBS), as above, and then mixed overnight 
on a rotator at 4oC in the same buffer. The beads were collected as before and 
resuspended in 0.1% (w/v) BSA/HBSS to a final concentration of 4 x 108 beads/mL 
and stored at 4oC. 
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2.4      Cell Culture 
2.4.1    Preparation of decidual endothelial cell monolayer substrate:  
 
An aliquot of pooled decidual endothelial cells was recovered from liquid 
nitrogen, the cryogenic tube was thawed quickly in a 37oC water bath and the contents 
immediately transferred to a 15 mL centrifuge tube containing 10 mL of growth 
medium (40% pooled maternal serum +60% M199+ + 700μl endothelial cell growth 
supplement (ECGS)). The tube was centrifuged at 1000 g for 5 minutes and the cell 
pellet was resuspended in 10 mL of growth medium, transferred to a gelatin-coated 80 
cm2 flask, then the flask transferred into the incubator at 37oC in 5% CO2. 
 
The following morning (day 2), the endothelial cells were washed and re-fed with 
growth medium. At this stage, glass coverslips were put in 6-well or 12-well plates 
(according to specific experiments), were coated with collagen IV, (125 or 250 
μl/well), and the wells left to dry overnight in the laminar flow hood.  
 
On the third day, 0.5 mL (12-well plates) or 1 mL (6-well plates) 70% ETOH (v/v 
ETOH and sterile water) was added into each collagen-containing well, mixed well, 
aspirated, and the well rinsed with 1ml sterile water which was then aspirated. The 
decidual endothelial cells in the flask were washed in 9 mL of HBSS and 2mL of 
HBSS plus 2 mL of trypsin/EDTA solution was added for 5 minutes. When the cells 
detached, they were put into a 15 ml tube, any cells remaining in the flask were 
washed out with another 2 ml of HBSS. The trypsin was inactivated by addition of 
100 μl FCS, the endothelial cell suspension was centrifuged at 1000 g for 5 min, the 
supernatant discarded, and cells resuspended with growth medium and added to the 
collagen-coated wells in the multi-well plates at a final concentration of 2.5x 105 
cells/ml (12 well plates) or 5x 105 cells/ml (6 well plates) 
  
On the third day monocytes were isolated as described above and pre-incubated in the 
different conditions (as described below), prior to adhesion co-culture experiments in 
the multi-well plates. 
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2.4.2  Pre- incubation of monocytes 
 
              Isolated monocytes were suspended in culture medium 2% FCS + M199- 
(this medium was suitable for monocyte culture because it maintains good cell 
viability with minimum activation) at a concentration of 105 monocytes / tube in a 
total volume of 1 ml.    
 Cells were pre-incubated in Immuno Minisorp tubes (these are designed to inhibit 
cell adherence) at 370C in 5 % CO2
 
  for 15 minutes and  then for 1 hour in the 
following conditions:  
 
(i) Basal,  
(ii) With 100μg/ml of bacterial lipopolysaccharide (LPS),  
(iii) With 25mM Glucose  
(iv) With 5μl/ml anti Mac-1 blocking antibodies and  
(v) With isotype Mouse IgG. 
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2.4.3  Adhesion assay 
 
Confluent endothelial cell monolayers in multi-well plates were washed with 
2% FCS+M199-, and monocytes seeded onto this monolayer in 2% FCS+M199-. 
After one hour at 370 C in 5 % CO2
(i) 
, non adherent cells were removed by gentle 
washing. 
 
After that the cells were treated in one of two ways: 
 
12 well plates
 
Wells with coverslips (containing monocytes adherent to endothelial cells) 
were fixed with 4% paraformaldehyde and  stored at 4
  
0
(ii) 
C until later immunostaining 
for monocyte cell counts  
 
6-well plates and some 12-well plates
 
Cells were removed from the coverslips by trypsinisation with 1mM EDTA 
for 5-7 minutes, then 0.1 % BSA in 50 ml PBS, was added to each well to inactivate 
the trypsin. The resultant mixed cell population (containing monocytes and decidual 
endothelial cells) was transferred into a corresponding 15 ml tube.  
 
To ensure complete cell harvesting, 0.5 ml PBS/0.1% BSA was added to each well, 
rinsed well and transferred into the same 15 ml tube. The mixed cell populations were 
centrifuged for 5 min at 1000 rpm  and transferred to Eppendorf tubes, where they 
were washed twice more with 1 ml of PBS/0.1% BSA prior to flow cytometry. 
 
  
2.5 Flow cytometry 
 
For analysis of adhesion and adhesion molecules, and after the relevant 
experiments cell populations of (a) monocytes alone, (b) PBMCs alone (c) endothelial 
cells alone and (d) the 2 cell populations together (monocytes and endothelial cells) in 
co culture were processed for flow cytometry.  
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Fig 2.4  Forward scatter is sensitive to surface properties of particles and is  
equivalent to particle size, whereas side scatter is more sensitive to inclusions within 
cells, and is able to distinguish granulated from non-granulated cells 
 
 
2.5.1    Antibody labelling for Flow cytometry 
2.5.1.1  Identification of monocytes and decidual endothelial cells.  
 
Adhesion of monocytes was quantified by immunostaining. Monocytes were 
identified as CD14 or CD 45 positive cells depending on the experiments, decidual 
endothelial cells were identified as CD45 negative cells.  
 
 
 
 
 
 
 
 
Side scatter detector 
Light source 
Forward 
Scatter detector 
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Fig 2.5   Decidual endothelial cells isolated from normal pregnant women.  
A Cell population based on forward scatter (FSC) and side scatter (SSC), this figure 
shows a representative flow cytometric analysis of one population decidual 
endothelial cells. Based on FSC or cell size, a gate R1 which represents decidual 
endothelial cells, was set on the FSC vs. SSC plot to allow analysis of cells  
B  99% of Decidual endothelial cells are seen in lower left quadrant, and it was 
identified as CD45 negative cells C Negative control   
 
A 
B 
 
C 
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Fig 2.6   A Cell subpopulations based on forward  scatter (FSC)  and side scatter 
(SSC), This figure shows a representative flow cytometric analysis of two populations 
- monocytes and decidual endothelial cells. Based on FSC or cell size, a gate R1 
which represents monocytes, and R2 which represents DEC, was set on the FSC vs. 
SSC plot to allow analysis of the two cell types. B Monocytes are seen in the LR 
quadrant as CD 45 Positive cells, while C 99.7% of Decidual endothelial cells are 
identified in LL quadrant as CD 45 negative cells. 
 
A 
C 
B 
99.7% 
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2.5.1.2   Identification of adhesion molecules on monocytes and decidual 
endothelial cells  
                 
To examine expression of adhesion molecules by monocytes, double labelling 
with CD14/PE and adhesion molecule/FITC was used.  The adhesion molecules 
examined were CD11b (Mac-1), CD11a (LFA-1) and CD49 d (VLA-4). 
The expression of the decidual endothelial cell adhesion molecule  ICAM-1 was 
examined in co culture with monocytes in normal and stimulated conditions, by 
double staining with CD45PE. 
 
Cells (monocytes alone, decidual endothelial cells alone, or the 2 cells from co-
cultured wells) were resuspended in 50 μl (final volume) of PBS/0.1% BSA, the 
conjugated antibody of interest was added (5 μl/ ml), and the cells were incubated 
with the antibody for 40 minutes at 40C. 
After 40 minutes the mixed cells were washed in 1 ml PBS/0.1% BSA  and 
centrifuged in an Eppendorf centrifuge (14000 g , 20 seconds) and fixed in 250 μl 1% 
PFA in PBS/0.1%BSA and refrigerated at 40
For analysis of monocyte adhesion molecules and level of monocyte 
adherence to decidual endothelial cells, isolated PBMCs and mixed cells including 
monocytes and decidual endothelial cells were processed for flow cytometry 
C until proceeding with flow cytometry. 
 
The cells were analysed on a Becton Dickinson flow cytometer (BD FACSVantage 
SE) with an argon laser at 488nM for analysis of PE and FITC. Ten thousand events 
were collected from a mixed (monocyte-decidual endothelial cell) population or from 
a pure monocyte population (depending on the experiments). Specific cells were 
identified from forward and side scatter dot plots. 
 
Data collected from the flow cytometer were stored electronically for later analysis on 
Cell Quest software. 
 
    
2.5.1.3     Flow cytometric analysis of monocyte adhesion molecules  
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acquisition using 2.5x 105 cells per test or 5x 105 cells per test depending on the 
experiment. 
Monoclonal antibodies Mac-1, LFA-1 and VLA-4 conjugated to fluorescein 
isothiocyanate (FITC) were used in mixed PBMC cell populations to detect monocyte 
adhesion molecules, using double staining with a monoclonal antibody to CD14 
conjugated to Phycoerythin (PE) to identify the peripheral blood monocytes. 
PBMCs were aliquoted into 1.5 ml Eppendorf tubes and pelleted by centrifugation at 
14000 g for 15 seconds at 200C.  
The cell pellet was resuspended in 50 μl of PBS/0.1%/BSA. 5 μl of  anti Mac-1 FITC,  
anti LFA-1 FITC, anti CD14 PE  and  anti VLA-4  FITC were incubated with the 
cells.  Mouse IgG FITC (5 μl) and mouse IgG PE (5 μl) were used as negative 
controls. 
 
Fig 2.7   Cell subpopulations based on forward  scatter (FSC)  and side scatter (SSC). 
It  shows a representative flow cytometric analysis of PBMCs. Based on FSC or cell 
size, a gate R1 was set on the FSC vs. SSC plot to allow analysis of monocytes only. 
 
Monocytes  
Lymphocytes 
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Fig 2.8   Quadrant markers divide two-parameter plots into four sections to 
distinguish populations that are considered double negative, single positive, or double 
positive. The lower left quadrant displays events that are negative for both parameters. 
The upper left quadrant contains events that are positive for the Y axis (CD14PE), but 
negative for the X axis  (Mac-1 FITC). The lower right quadrant contains events that 
are positive for the X axis (Mac-1 FITC), but negative for the Y axis (CD14 PE). The 
upper right quadrant contains events that are positive for both parameters 
(CD14PE/Mac-1 FITC).  
 
 
 
 
 
 
 
 
 
Mac-1 FITC 
CD 14 PE 
Expression  of adhesion 
molecule MAC-1 on 
monocytes  
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2.5.1.4    Flow cytometric identification of decidual endothelial cells  
 
For identification of decidual endothelial cells after co-culture experiments 
with monocytes, staining with a monoclonal antibody to CD45 (conjugated to 
Phycoerythin (PE) and a monoclonal antibody to ICAM-1 (conjugated to fluorescein 
isothiocyanate) was used. 
 
The antibodies were incubated with the cells for 40 minutes at room temperature in 
the dark, and then cells were washed twice in 1 ml of PBS/0.1%/ BSA, pelleted by 
centrifugation at 14000 rpm for 15 seconds at 200
 
 
C (Eppendorf Centrifuge 5417R), 
and fixed with 1 % paraformaldehyde. 
 
 
 
 
Fig 2.9   Cell subpopulations based on Forward scatter (FSC) and Side scatter (SSC). 
Figure 2.11 shows a representative flow cytometric analysis of mixed cell population 
of monocytes, endothelial cells. Based on FSC or cell size, a gate R1  was set on the 
FSC vs. SSC plot to identify the decidual endothelial cells, R2 to identify the 
monocytes.   
 
Decidual endothelial cells  
Monocytes 
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Fig 2.10   Dot plots, shown in Figure 2.12 provide a two-parameter display of data in 
co culture. Quadrant markers divide two-parameter plots into four sections to 
distinguish populations that are considered double negative, single positive, or double 
positive. The lower left quadrant displays events that are negative for both parameters. 
The upper left quadrant contains events that are positive for the Y axis (CD45PE), but 
negative for the X axis  (ICAM-1 FITC). The lower right quadrant contains events 
that are positive for the X axis (ICAM-1 FITC), but negative for the Y axis (CD45 
PE). The upper right quadrant contains events that are positive for both parameters 
(CD45PE/ICAM-1 FITC).  
   
 
 
 
 
 
 
 
 
Expression of ICAM-1 on DEC 
Monocytes 
ICAM-1 FITC 
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Fig 2.11     Dot plots provide a two parameter display of data. 
Adhered monocytes were identified as CD14 PE positive cells.  
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2.6  Statistical analysis 
 
Where relevant, group data are shown as mean and standard deviation, after 
initial examination to determine the normality of data distribution. Examination of the 
effects of stimulation within groups was performed by paired Student t test, while 
differences between groups (normal and diabetic) were analysed by the Kruskal- 
Wallis test for non parametric variables. Differences were considered statistically 
significant at P < 0.05.  
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3.  Introduction  
 
As described in Chapter 1, in pregnant women with T1DM, a vascular 
abnormality, atherosis, similar to atheroma in the non-pregnant, develops over a 
relatively short space of time within the maternal blood vessels supplying the 
placenta. There is a growing body of evidence that monocytes are preferentially 
recruited to the arterial intima early in the development of atheromatous lesions 
(Schwartz et al, 1991).  
 
Monocyte adherence to endothelial cells is the first step required for migration of 
monocytes from blood into tissue. Exposure to a variety of cytokines can result in 
activation of adhesion molecules on monocytes and endothelium that cause firm 
adhesion to the endothelium (Beekhuizen, 1993). Adhesion molecules on monocytes 
that have been implicated include very late antigen (VLA-4), leucocyte function 
antigen (LFA-1)  and complement receptor MAC-1 (Beekhuizen et al., 1990), 
whereas endothelial cell adhesion molecules likely to be involved include intercellular 
adhesion molecule-1 (ICAM-1), intercellular adhesion molecule-2 (ICAM-2), 
vascular cell adhesion molecule-1 (VCAM-1), P selectin (CD62) and E-selectin 
(ELAM-1) ( Pober JS et al., 1990; Benkhuizen H, et al., 1991). 
 
The definitive mechanisms regulating the initiation and progression of vascular 
lesions in diabetic pregnancy have yet to be elucidated. Earlier work in our group had 
shown increased in vitro adhesion of monocytes from T1DM pregnancy to decidual 
endothelial monolayers (Galettis et al., 2004). The experiments reported in this 
chapter were performed to examine in more detail the regulation of this process. In 
particular are described experiments examining the expression of relevant adhesion 
molecules by monocytes from normally pregnant women and those with diabetes 
mellitus, and factors that influence both the adhesion of monocytes to decidual 
endothelial cells isolated from the pregnant human uterus and their expression of 
relevant adhesion molecules. 
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3.1    Aims 
 
The specific aims of the experiments reported in this chapter were: 
 
i) To identify the monocyte adhesion molecules associated with increased 
peripheral blood monocyte adhesion to decidual endothelial cells in T1DM 
pregnant women. 
ii) To define mechanisms involved in regulation of monocyte adhesion to 
decidual endothelial cells in normal pregnancy and in T1DM pregnancy 
 
A series of preliminary experiments was performed to select the most appropriate 
antibodies for monocyte identification.  
Then dose response curves were performed to optimise antibody-antigen interactions 
for relevant monocyte adhesion molecules (LFA-1, MAC-1 and VLA-4).  
 
   3.2      Identification of monocytes  
 
Peripheral blood monocytes were isolated by gradient density centrifugation, 
as described in chapter 2, then the cells were analysed for level of expression of CD14 
and CD68 to determine which was of greater utility for recognition of the majority 
monocytes 
 
A double-staining method was used for surface markers CD14 (conjugated and 
unconjugated) and CD68 (conjugated and unconjugated) (Figure 3.2.1) 
There was no specific staining when using the unconjugated CD68 compared with the 
negative control, whereas the mean fluorescence intensity of conjugated CD14 was 
significant, compared with the negative control. 
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Figure 3.1   a representative histogram charting the number of cells counted and the 
fluorescence intensity (MFI). The MFI of the CD14 FITC was significant compared 
with the unconjugated CD68. 
 
 
The experiment was repeated using conjugated CD14, unconjugated CD68 and 
unconjugated CD 14 (the reason for using unconjugated  CD14 was to test the 
secondary antibody, which is Goat anti mouse FITC, to clarify whether the lack of 
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staining of the unconjugated CD68 was due to antibody malfunction  or because of an 
error in the secondary antibody). 
 
The mean fluorescence intensity for unconjugated CD14 was significantly higher than 
the negative control, and equal to that of the conjugated CD14, whereas the 
unconjugated CD68 failed to show a specific and significant binding compared with 
the background staining of negative control (Figure 3.2) 
 
 
Figure 3.2   a representative histogram charting the number of cells counted and the 
fluorescence intensity (MFI). The MFI of the unconjugated CD14   was significant, 
whereas there was a lack of staining with the unconjugated CD68 
 
 
 
Because CD68 FITC is directed against an intracytoplasmic antigen, permeabilisation 
of the cells was necessary before incubation.  
Both conjugated CD14 and CD68 were able to recognise the majority of the 
monocyte population, however using flowcytometry, conjugated CD14 was positive 
in a greater proportion of the monocyte population (figure 3.2) 
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Figure 3.3   a representative histogram charting the number of cells counted and the 
fluorescence intensity (MFI). The MFI of the CD14 FITC was significant compared 
with the unconjugated CD68.CD14 PE labelling was used for subsequent adhesion 
molecule experiments. 
 
 
 
Sample ID :MIgG PE 
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3.3  Adhesion molecule dose-response curves 
 
Antibody-antigen dose response curves for adhesion molecules LFA-1, VLA-
4 and Mac-1 were done to determine the optimal antibody concentration for 
subsequent experiments . This is an essential optimisation step, because too high a 
concentration of antibodies causes increased levels of non specific background of 
staining, and too low a concentration results in poor display of antigen expression. 
Peripheral blood mononuclear cells (PBMCs) were isolated from whole blood as 
described in chapter 2. The cells were immunolabelled by using the double staining 
method with conjugated CD 14 to identify the monocytes and the adhesion molecule 
antibody to identify the specific adhesion molecule under examination, then the 
samples were analysed by flow cytometry. Results are shown in figures (3.1-3.2 and 
3.3) 
MFI of cells increased in dose dependent manner for each adhesion molecule 
examined (LFA-1, VLA-4 and MAC-1) 
3.3.1.    LFA-1 dose response curve 
 
LFA-1 Dose response curve
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Figure 3.4   a dose-response curve for LFA-1: maximum MFI of LFA-1 was at a final 
antibody concentration of 5 mcg/ ml (5x105  cells) 
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3.3.2    Mac-1 dose response curve 
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Figure 3.5   a dose-response curve for MAC-1: maximum MFI of Mac-1 was at  a 
final antibody concentration of 5 mcg/ml (5x105  cells) 
 
3.3.3 VLA-4  dose response curve 
 
 
 
Figure 3.6   a dose-response curve for VLA-4: maximum MFI of VLA-4 was at a 
final antibody concentration of 5 mcg/ml (5x105  cells) 
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3.4  Comparison of adhesion molecule expression by monocytes from normal     
pregnant women and those with diabetes mellitus.   
3.4.1   Subjects 
As outlined in Chapter 2, three groups of subjects (n=14 in each group), aged 
between 23 and 41 years, were studied in the third trimester of pregnancy, 
 (i) normal (N) 
 (ii) type I diabetes (T1DM) and  
(iii) gestational diabetes (GDM) 
 
3.4.2   Methods 
A mixed population of peripheral blood mononuclear cells and monocytes 
were isolated from peripheral blood as described in Chapter 2 (sections 2.2.2.1 and 
2.2.3.1) 
 
To examine expression of adhesion molecules by monocytes, double labelling with 
CD14/PE and adhesion molecule/FITC was used.  The adhesion molecules examined 
were MAC-1, LFA-1 and VLA-4. Cells were analysed on a Becton Dickinson flow 
cytometer (BD FACSVantage SE) with an argon laser at 488nM for analysis of PE 
and FITC. Ten thousand events were collected from a pure monocyte population. The 
monocytes were identified from forward and side scatter dot plots. Data collected 
from the flow cytometer were stored electronically for later analysis on Cell Quest 
software. 
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3.4.3 Results   
3.4.3.1  Level of expression of adhesion molecule LFA-1 
Peripheral blood monocytes from T1DM pregnant women expressed higher 
levels of adhesion molecule LFA-1 than monocytes from both normal pregnant 
women and those with gestational diabetes (P<0.01) (Figure 3.4.3.1.1). There was no 
difference in the level of expression of LFA-1 in normal pregnancy compared with 
gestational diabetes.   
                                                             
 
Figure 3.7: Bar chart representing levels of expression of adhesion molecule LFA-1 
from Gestational diabetic, Type I diabetic and normal pregnancy      x= P<0.01 
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3.4.3.2   Expression of adhesion molecule MAC-1 
Peripheral blood monocytes from T1DM pregnant women expressed higher 
levels of adhesion molecule MAC-1 compared with monocytes from normal  
pregnancy and GDM (P<0.01) (Figure 3.4.3.2.1) whereas there was no significant 
difference in the level of expression of MAC-1 between normal pregnancy and GDM. 
 
 
Figure 3.8  Bar chart representing levels of expression of adhesion molecule Mac-1 
from Gestational diabetic, Type I diabetic and normal pregnancy x=P<0.01 
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3.4.3.3  Expression of adhesion molecule VLA-4 
There was no significant difference in the expression of monocyte adhesion 
molecule VLA-4 from T1DM pregnant women compared with normal pregnant 
women or those with GDM (Figure 3.4.3.3.1) 
 
 
 
 
 
 
 
 
 
Figure 3.9  Bar chart representing levels of expression of adhesion molecule VLA-4 
from Gestational diabetic, Type I diabetic and normal pregnancy. There were no 
significant differences amongst groups 
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3.5 Mechanisms involved in upregulation of monocyte adhesion molecules and 
adhesion to decidual endothelial cells in normal pregnancy and in  type I 
diabetic pregnancy 
 
3.5.1 Introduction  
 
The adhesive properties of blood monocytes are important under normal 
steady-state (i.e. non- inflammatory) conditions as well as in response to 
inflammation. Under non- inflammatory conditions the adhesion properties of blood 
monocytes are not stimulated and the efflux of monocytes from the blood stream to 
the tissues ensures maintenance of the macrophage population in a given tissue 
compartment. In response to inflammation, adhesion and sequestration of circulating 
monocytes is increased and the recruitment of large numbers of blood monocytes to 
the tissues satisfies the increased demand for tissue macrophages. (Issekutz, 1981) 
(Blusse, 1983). Under steady-state conditions integrin molecules on the monocyte cell 
surface are in a relatively inactive state and upon stimulation , these molecules 
convert to an active state with high affinity for their ligands ( Hynes, 1992) ( Dobrina, 
1991). After initial experiment comparing normal and diabetic monocytes , 
mechanisms of regulation of adhesion molecules was further explored using cells of 
normal and diabetic pregnant women. 
 
3.5.2 LPS dose- and time- response curve 
 
          Activation of monocytes with mediators of inflammation such as bacterial 
lipopolysaccharide (LPS), results in rapid degranulation of intracellular stores and 
increased surface expression of various adhesion molecules (Bainton, 1987) (Miller, 
1987). We therefore studied the effects of LPS on monocytes from normal and 
diabetic pregnant women  
 
In preliminary experiments LPS dose- and time- response curves were determined. 
Monocytes isolated from peripheral blood were incubated with 10ng/ml, 100 ng/ml 
and 1000 ng/ml of LPS for 20 min, 60 min and 120 min, and then were double stained 
with (CD14) PE and  (MAC-1) FITC. 
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The results are summarised in Figures 3.10 and 3.11 Upregulation of MAC-1 
expression was maximal at 30 min and with LPS concentration at 100 ng/ml. 
The time and dose response experiments were repeated three times. 
 
 This LPS stimulation experiment was undertaken on monocytes from normal 
pregnancies only, as other projects in our group examined the response to stimulation 
of monocytes from diabetic subjects. The current set of experiments used a  
proinflammatory mediator (LPS) to change the status of normal monocytes towards 
that of diabetic monocytes in term of inflammation.  
 
Figure 3.10  Time response curve of adhesion molecule expression in response to 
100ng LPS stimulation. Upregulation of MAC-1 expression was maximal at 30 min. 
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Figure 3.11  Dose response curve of adhesion molecule expression in response to LPS 
stimulation. Upregulation of MAC-1 expression was maximal with LPS concentration 
at 100 ng/ml. 
 
In subsequent experiments, monocytes were isolated by density gradient 
centrifugation as described earlier in chapter 2 (section 2.2.2.1) pre-incubated in 
Immuno Minisorp tubes with 100 ng/ml of bacterial lipopolysaccharide (LPS), at  
370C in 5 % CO2  for 30 minutes.  The effect of stimulation by LPS was examined in 
normal pregnant women (N=14), in the third trimester of pregnancy, aged between 23 
and 41 years. Experiments examined MAC-1 expression, known to be significant for 
diabetic subjects.  
 
3.5.3.1   LPS stimulation of isolated monocytes  
 
          Monocytes were suspended in culture medium 2% FCS + M199- at a 
concentration of 105 cells / tube in a total volume of 1 ml. Cells were pre-incubated in 
Immuno Minisorp at 370C in 5 % CO2  for 30 minutes with  100μg/ml of bacterial 
lipopolysaccharide (LPS), then fixed, stained with CD14/PE and MAC-1/FITC, and 
analysed by flow cytometry. 
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3.5.3.2  Results  
Figure 3.5.3.2.1  is a graphic representation of flow cytometry analysis There was a 
significant increase of MAC-1 expression in monocytes stimulated by LPS, compared 
with the unstimulated group.  
 
Figure 3.12  MAC-1 expression on CD14+ monocytes from normal pregnant women. 
Pre-stimulation with LPS caused an up-regulation of MAC-1 P< 0.01 
3.5.4 Adhesion assay:  regulation of adherence of monocytes from normal 
pregnant women to decidual endothelial cell 
This series of experiments examined the effect of pre-treatment of monocytes 
with LPS on their adhesion to decidual endothelial cells  
Cell isolation and for preparation is described in detail in Chapter 2.  
3.5.4.1  Assessment of monocyte-decidual endothelial cell adhesion 
 
Confluent endothelial cell monolayers in 6 well plates were washed with 2% 
FCS+M199-, and monocytes in 2% FCS+M199- (control and LPS-stimulated) were 
seeded onto this monolayer. After one hour incubation at 370 C in 5 % CO2, non 
adherent monocytes were removed by gentle washing. Cells were then removed from 
the 6 well plates with trypsin+EDTA (5-7 min), then 0.1 % BSA in 50 ml PBS was 
added to each well to inactivate the trypsin.  
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The resultant mixed cell population (containing monocytes and decidual endothelial 
cells) was transferred into a corresponding 15 ml tube. The mixed cell populations 
were centrifuged for 5 min at 1000 rpm and transferred to Eppendorf tubes, where 
they were washed twice more with 1 ml of PBS/0.1% BSA. 
 
Cells were resuspended in 50 µl (final volume) of PBS/0.1% BSA, for flow 
cytometry. Aliquots were double stained with (CD45 PE + ICAM-1 FITC) for 
identification of monocytes (CD45 PE positive) and for identification of endothelial 
cells (ICAM-1 FITC positive).   
(See figure Fig 2.6, 2.7 and 2.12 in Chapter 2).  
 
Antibody was added (5 mcg/ ml), and the incubation conducted at 40C. After 40 
minutes the mixed cells were washed in 1 ml PBS/0.1% BSA , centrifuged in an 
Eppendorf centrifuge (14000 g , 20 seconds), fixed in 250 µl 1% PFA in 
PBS/0.1%BSA and refrigerated at 40C until proceeding with flow cytometry. The 
cells were analysed on a Becton Dickinson flow cytometer (BD FACSVantage SE) 
with an argon laser at 488nM for analysis of PE and FITC. Ten thousand events were 
collected from a mixed (monocyte-decidual endothelial cell) population or from a 
pure monocyte population (depending on the experiments). Data collected from the 
flow cytometer were stored electronically for later analysis on Cell Quest software. 
 
3.5.4.2   Results  
 
3.5.4.2.1 Adhesion 
 
As shown in Figure 3.5.4.2.1 LPS pre-treatment of monocytes resulted in 
significant stimulation of adhesion to the decidual endothelial cell monolayer (30+% 
vs 45+%, p< 0.01 )  
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Figure 3.13   Pre-stimulation of monocytes from normal pregnant women with LPS 
causes an up-regulation of the number of adhered monocytes to decidual endothelial 
cell 
 
Monocyte adhesion, to the decidual endothelial cell monolayer was not associated 
with any further increase in MAC-1 expression (not shown)  
3.5.4.2.2 Effect of co-culture with monocytes on ICAM-1 expression by 
decidual endothelial cells 
ICAM-1 a single-chain glycoprotein, expressed on decidual endothelial cells, 
has MAC-1 as a major ligand. An interaction between these molecule is a potential 
mechanism for regulation of adherence of monocytes to vascular endothelium, and the 
co-culture experiments conducted afforded an opportunity to examine the effect of the 
presence of monocytes on the expression of ICAM-1 by decidual endothelial cells.( 
Rothlein, 1986) (Marlin, 1987) (Markgoba,1988). 
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The expression of the decidual endothelial cell adhesion molecule ICAM-1 was 
examined in co culture with monocytes in normal and stimulated conditions, by 
double staining (CD45PE + ICAM-1 FITC) 
 
               3.5.4.3.3   ICAM-1 Results 
     
                The MFI of ICAM-1 on normal pooled decidual endothelial cells (NDEC) in 
co-culture with non activated monocytes was significantly higher than the levels of 
ICAM-1 expression of the DEC alone. Interestingly, although LPS stimulated both 
MAC-1 expression in monocytes, and their adhesion to DEC, such prior stimulation 
of the monocytes had no effect on DEC ICAM-1 expression.  
 
Figure 3.14 There was an increase in expression of ICAM-1 from normal DEC in co 
culture (CC) with non activated monocytes compared with their baseline ICAM-1 
expression, but there was no significant further increase with the pre-stimulated 
monocytes 
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3.6 Effect of blocking MAC-1 expression on monocytes on their adhesion to 
decidual endothelial cells.  
 
3.6.1 Introduction  
 
             Earlier work from our group (Galettis et al 2004) had shown increased 
adherence of monocytes from pregnant women with type I diabetes to  normal 
decidual endothelial cells. Following demonstration that MAC-1 is up-regulated in 
monocytes from type I diabetic pregnant women, that these monocytes adhere more to 
DEC and that activation of MAC-1 on monocytes from normal subjects stimulates 
their adherence to DEC, the effect of blocking MAC-1 expression on monocytes was 
investigated. These experiments were conducted using monocytes from both normal 
pregnant women and those with T1DM. The effect of this antibody blockade was 
examined in control and LPS-stimulated monocytes. The effect of high glucose 
concentrations was also examined, as this is relevant to the study of adhesion 
molecule expression in T1DM. (Baumgartner- Parzer, 1995). 
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3.6.2 Blocking MAC-1 on monocytes in normal subjects 
3.6.2.1 Subjects 
 
Subjects involved in this part of the study were normally pregnant women in the third 
trimester of pregnancy, as described in Chapter 2 (n=12) 
3.6.2.2 Materials and Methods 
The preparation of normal pooled decidual endothelial cells was as described 
in chapter 2.  
2.6.2.2.1   Pre- incubation of monocytes 
 
Isolated monocytes were suspended in culture medium 2% FCS + M199- at a 
concentration of 105 monocytes / tube in a total volume of 1 ml. Cells were pre-
incubated in Immuno Minisorp tubes 370C in 5 % CO2 in the following conditions:  
 
(i)  Control    
(ii)With 5μl/ml anti Mac-1 blocking antibodies for 15 minutes  
(iii) With 100μg/ml of bacterial lipopolysaccharide (LPS) for 30 min and then  
with 5μl/ml anti MAC-1 blocking antibodies for 15minutes 
(iv) With 25mM Glucose for one hour 5μl/ml anti MAC-1 blocking antibodies 
for 15 minutes. 
  
3.6.2.2.2      Assessment of monocyte-decidual endothelial cell adhesion 
 
Confluent endothelial cell monolayers in 12 well plates were manipulated  as 
described above. 
  
 
 Assessment of monocyte adherence 
 
(A) Immunostaining: Wells with coverslips (containing monocytes adherent to 
endothelial cells) were fixed with 4% paraformaldehyde and stored at 40C until later 
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immunostaining with CD68 for monocyte cell counts to confirm visually the 
flowcytometry data . 
 
(B) Flow cytometry: Cells (containing monocytes and decidual endothelial cells) were 
removed from the well and separated by trypsin/EDTA for 5-7 minutes, then 0.1 % 
BSA in 50 ml PBS was added to each well to inactivate the trypsin. The resultant 
mixed cell population was transferred into a corresponding 15 ml tube.  
To ensure complete cell harvesting, 0.5 ml PBS/0.1% BSA was then added to each 
well, rinsed well and transferred into the same 15 ml tube. Wells were visually 
inspected after this step to ensure there were no residual cells. The mixed cell 
populations were centrifuged for 5 min at 1000 rpm and transferred to Eppendorf 
tubes, where they were washed twice more with 1 ml of PBS/0.1% BSA prior to flow 
cytometry. 
 
Cells  were resuspended in 50 µl (final volume) of PBS/0.1% BSA, Monocytes were 
identified as CD14+ positive cells  and decidual endothelial cells as CD45- negative 
cells. After 40 minutes the mixed cells were washed in 1 ml PBS/0.1% BSA  and 
centrifuged in an Eppendorf centrifuge (14000 rpm , 20 seconds) and fixed in 250 µl 
1% PFA in PBS/0.1%BSA and refrigerated at 40C until proceeding with flow 
cytometry as described earlier. 
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3.6.3 Blocking MAC-1 in baseline in normal subjects results 
                As shown in (figure 3.15), antibody blockade of MAC-1 resulted in significant 
inhibition of monocyte adherence to decidual endothelial cells from normal 
pregnancy. 
 
                     
 
Figure 3.15  There was a decrease in monocyte adherence to DEC in co culture after 
blocking  MAC-1  P<0.01 
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3.6.4  Blocking MAC-1  after LPS stimulation in normal subjects 
MAC-1 antibody blockade virtually abrogated the stimulation of monocyte 
adhesion induced by LPS, as shown in Figure 3.16 
                 
Figure 3.16: There was a decrease in monocyte adherence to DEC in co culture 
after stimulation with LPS and blocking the MAC-1 (P<0.01) 
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3.6.5 Blocking MAC-1 after Glucose stimulation in normal subjects  
                 As can be seen in Figure 3.17, pre-incubation of monocytes with high glucose 
levels (25 mmol/l) resulted in a significant stimulation of their subsequent adherence 
to the decidual endothelial cell monolayer. Blockade of MAC-1 inhibited this 
adherence. 
 
Figure 3.17 There was a decrease in monocytes adherence to DEC in co culture after 
stimulation with Glucose and blocking the MAC-1 (P<0.01) 
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3.6.6 Immunostaining of blocking MAC-1 in normal subjects results  
The wells with coverslips (containing monocytes adherent to endothelial cells) 
were fixed with 4% paraformaldehyde and stored at 40C until later immunostaining 
for monocyte cell counts. Monocytes were Immunolabelled and identified with mouse 
anti human CD68 (clone EBM11, 1: 100 dilution) 
As shown in Figure 3.6.3 immunostaining analysis confirmed the flow results., 
Blockade of MAC-1 on monocytes, resulted in significant inhibition of their 
subsequent adherence to decidual endothelial cells. 
 
Throughout this body of work, flow cytometry was used to identify adhesion 
molecule expression, while monocyte-decidual endothelial cell adhesion was assessed 
by immunocytochemistry. 
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Figure 3.18: There was a decrease of the number of adhered monocytes to DEC from 
normal subjects in co culture after blocking with anti MAC-1 P<0.01 
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Picture 3.1 Immunostaining of co culture experiment in normal subjects. Brown 
colour shows the Immunostained CD68 positive cells , expressing the adhered 
monocytes from normal pregnancy, A- baseline, B- blocking. 
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3.6.7    Blocking MAC-1 on monocytes in T1DM pregnant subjects 
 
Figure 3.19: There was a decrease of the number of adhered monocytes from type I 
diabetic pregnancy to DEC in co culture after  blocking with MAC-1 P<0.01 
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Picture 3.2 Immunostaining of co culture experiment in T1DM subjects Brown colour 
shows the Immunostained CD68 positive cells , expressing the adhered monocytes 
from type I diabetic pregnancy, A- baseline and B- after blocking 
A 
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4.1 Introduction     
 
The immune system is complex and the changes necessary to accommodate 
successful pregnancy are incompletely understood. Published evidence of both 
immunosuppression and immune activation supports the concept of a unique 
alteration in the balance between innate and adaptive immune systems. The results 
presented in this thesis further expand the knowledge of pregnancy-associated 
changes in the activation and function of monocytes, central players in the innate 
immune system, and the potentially deleterious abnormalities that are seen in type 1 
diabetes mellitus (T1DM).  
 
Using a co culture model, mechanisms that regulate the adhesion between monocytes 
and endothelial cells have been investigated. Better understanding of these regulatory 
mechanisms may eventually assist therapeutic approaches to the prevention or 
treatment of diabetic vascular complications, particularly in pregnancy.  
 
4.2 Non-immune functions of immune cells    
           
Cells of the immune system have multiple functions, and diseases not classically 
thought of as immune in origin may have an immune component as evidenced by 
abnormal function of cells of the immune systems. Atherosclerosis is one such 
macrovascular disease. Atherosclerosis is common in patients with long term diabetes 
mellitus (Bilato and Grow, 1996; Vlassara, 1996; King and  1996). Hyperglycemia 
and advanced  glycation end products (AGE) ( Brownlee, 1995) are the two best 
recognised important factors in the development of macrovascular disease . 
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The atheroma of diabetes mellitus is associated with abnormal local tissue 
macrophage function, and there is a growing body of evidence that this cell’s 
precursor in the circulation, the blood monocyte, also shows abnormal function.  
 
A number of reports have attested to activation of the innate immune system in 
normal human pregnancy (Fear on, 1996, Luppi, 2002, Sacks 1999,) and indicate a 
significant role for monocytes. In normal pregnancy, activation of the innate immune 
system is necessary to maintain maternal health in the presence of relative suppression 
of the adaptive immune system. Such a fine balance is essential, and potential 
problems are encountered in mothers with underlying vascular pathology or immune 
disorders that reduce her capacity to maintain a tight regulation of adaptation to 
pregnancy. Diabetes is accompanied by significant vascular pathology and 
pathophysiology. Although the majority of women with underlying diabetes have 
successful pregnancies, they are at increased risk of systemic micro- and 
macrovascular complications. If this vascular pathology manifests within the 
specialised uteroplacental circulation, there is an increased chance of reduced 
placental blood flow, putting the fetus at particular risk, both of growth restriction and 
of death.  
 
The recognition that an atheroma-like pathology, with prominent monocyte-
macrophage infiltration, occurs within an accelerated time frame in the maternal 
blood vessels of the placental bed raised the possibility that maladaptation of the 
peripheral blood monocyte, already activated to accommodate pregnancy, is causally 
involved in production and progression of these vascular lesions. This led to the 
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studies conducted in this thesis, to investigate factors involved in monocyte adherence 
to endothelial cells of the placental bed, a necessary preliminary step in their 
migration through the decidual endothelium into the perivascular space. 
 
4.3 Hyperglycaemia as a cause of increased monocyte-endothelial cell adhesion 
  Our group had previously described increased  adhesion to decidual 
endothelium of monocytes from pregnant women with type 1 diabetes (Galettis et al, 
2004) . Such an increase could be the initial step in the development of placental bed 
vascular disease. The changes may nevertheless have been related to duration and 
adequacy of glycemic control, as HbA1c levels were higher in the type 1 diabetic 
group. Using this novel model, the current body of  work has investigated mechanisms 
by which this increased adhesiveness to placental bed endothelium occurs in diabetic 
pregnancy.  
The findings of this study demonstrate pre-existing activation of the peripheral 
blood monocyte in T1DM in pregnancy. It is clear that a marked increase in 
expression of integrins LFA1 and MAC-1 accompanies their elevated levels of 
adhesion to endothelial cells from the deciduum. Monocytes from both normal and 
diabetic pregnancies were responsive to stimulation by LPS and by high ambient 
levels of glucose, but cells from pregnancies with T1DM had more florid responses to 
all the stimuli examined, most likely due the chronic inflammatory status of diabetic 
monocytes and the chronic presence of inflammatory cytokines. 
 
One possible reason for these abnormalities is the presence of hyperglycaemia. 
Hyperglycaemia increases intracellular diacyglycerol synthesis via glycolysis and 
                                                                                                                          Chapter 4 
 102 
activates protein kinase C ( Xia et al., 1994). This second messenger activation leads 
to enhancement of glycolysis, thought to enhance the expression of monocyte 
integrins (Kim et al., 1994), a suggestion supported by the upregulation of monocyte 
expression of integrin MAC-1 found in T1DM pregnancies, and by their increased 
level of adherence to DEC. However, the results indicated that the increased levels 
were not due solely to high glucose levels, as values for women with gestational 
diabetes (who had comparable levels of blood glucose) were not as high as those with 
T1DM. Neither were they correlated simply with HbA1c levels at the time of blood 
collection, although it is likely that long term exposure to elevated levels of AGEs are 
at least in part responsible for the stimulation.   
 
Hyperglycaemia is undoubtedly of significance in increased monocyte-endothelial 
cell adhesion, at least some of which effect is due to stimulation of endothelial 
expression of adhesion molecules. Consistently, hyperglycemia has been shown to 
induce monocyte adhesion molecule expression on the endothelium, and increased 
accumulation of white blood cells on the endothelium has been observed in models of 
streptozotocin- or alloxan-induced diabetes and hyperglycemia (Booth, 2002). Our 
research group has recently shown that exposing decidual endothelial cells to high 
glucose levels in vitro caused an increase in adhesion molecule expression and 
monocyte adhesion, indicating that hyperglycemia is sufficient for initiation of 
macrophage-rich lesions (Renard, 2004, Xie et al submitted for publication). In 
addition, monocytes isolated from normolipidemic hyperglycemic patients with 
T1DM have an increased binding ability to endothelial cells in vitro (Kunt, 1999).  
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4.4   Advanced glycation end-products (AGEs) as a cause of increased monocyte-
endothelial cell adhesion 
Another possible cause of increased monocyte-endothelial cell adhesion is the 
presence of high levels of advanced glycation end-products (AGEs) in T1DM 
subjects. Chronic hyperglycaemia causes no enzymatic glycation of circulating cells 
and proteins, resulting in production of advanced glycation end products (AGEs)  
(Kunt, 1999, Xia, 1994), with reduced nitric oxide synthase activity or decreased 
availability of L arginine, the substrate for nitric oxide (Tesfamariam, 1991, 1993), 
(Sobrevia, 1994). This, in combination with free radicals such as superoxide anions, 
which directly inactivate NO, are responsible for reducing the bioavailability of nitric 
oxide, the main factor responsible for vasodilation of endothelium and vascular 
smooth muscle, by elevating tissue levels of cyclic guanosine monophosphate (Ignaro, 
1987) .  
 
Nitric oxide (NO) inhibits key early processes of atheroma formation beginning with 
the signalling pathways which promote endothelial cell-monocyte interactions. The 
ability of monocytes to bind to endothelial cells in vitro is inhibited within minutes by 
exogenous NO in a dose dependent manner, suggesting that NO is a potent modulator 
of monocyte-vessel wall interactions (Tsao, 1995).  
Because of the rapid time course, this effect must be due to inhibition of signalling 
pathways involved in adhesion. More chronic exposure to NO suppresses gene 
expression of adhesion molecules and chemokines involved in monocyte adhesion 
and infiltration (Tsao and al 1997), By contrast, inhibition of NO synthesis increases 
the expression of endothelial proteins required for monocyte adhesion Tsao, Wang, 
Buitrago, and Cooke 1996)  
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4.5    Specific adhesion molecules involved in monocyte-endothelial cell adhesion. 
 
Monocyte adhesion to vascular endothelium is mediated by integrin receptors 
with a shared ß2 subunit and alpha subunit. (Jang, 1994), (Carlos, 1994). These 
include LFA-1 and Mac-1 on monocytes and their endothelial ligand intracellular 
adhesion molecule-1 (ICAM-1). ICAM-1 has low levels of constitutive expression on 
vascular endothelium (Dustin 1988, 1989), and is upregulated upon stimulation by 
chemoattractant inflammatory proteins or when in contact with other cells types, 
particularly monocytes.  
VLA-4 is a ß1 integrin ligand that promotes monocyte adherence to endothelial 
VCAM-1 and to connective tissue components, particularly the connecting segment 
part of fibronectin (Wayner, 1989).  Our finding that VLA-4 is not over-expressed in 
monocytes from T1DM pregnant women and therefore does not appear to play a 
major role in glucose mediated binding is consistent with that of Kim (1994) in non-
pregnant diabetic subjects. The results are also consistent with those of (Xiao- zhou 
(1998), who found that LFA-1 and Mac-1 alone can mediate monocyte adherence to 
endothelial cells and migration even when VLA-4 is blocked with monoclonal 
antibody. 
Mac-1 cell surface expression can increase rapidly as a result of translocation of 
stored receptor (Edwards, 1998), (Fontana, 2001). The highly significant increase 
observed in these experiments in the membrane expression of monocyte Mac-1 within 
30 minutes of stimulation with different stimuli suggests increased translocation of 
stored Mac-1 to the cell surface rather than increased Mac-1 mRNA and protein 
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synthesis. Such a mechanism could regulate the monocyte's ability to adhere to 
endothelial cells and migrate to the extravascular space (Miller, 1987). The regulation 
of integrin mediated adhesion appears to be a purely quantitative change in expression 
of these adhesion molecules on the surface rather than a change in their affinity for 
the respective ligands Stacker (1991). 
The significance of Mac-1 in regulating monocyte-DEC adherence was demonstrated 
clearly in this study in experiments with a specific monoclonal blocking antibody to 
Mac-1. The low level of adherence of monocytes to DEC seen in the absence of 
stimulation was reduced in the presence of antibody blockade, while the elevated 
levels induced by LPS pre-treatment were virtually abolished. 
 
4.6  Comparison of results in the present study with previous reports 
Few researchers have addressed the specific question of monocyte adhesion to 
endothelial cells of the placental bed in human pregnancy. In non-pregnant subjects, 
Sampson (Sampson, 2002) found an equivalent glucose-induced increase in Mac-1 
expression in both diabetic and control groups, and hypothesised that this pattern of 
response was due to an "all or none" Mac-1 translocation in response to any 
glycaemic excursion irrespective of basal plasma glucose. The findings of the current 
study in pregnant subjects in contrast, show a different degree of responsiveness in 
normal and T1DM pregnant subjects.  While the findings reported here are consistent, 
in direction if not in degree, with most previous reports dealing with non-pregnant 
subjects, some authors have found markedly different results.   
Martin et al (1991) found that the percentage of adhesion molecule LFA-1-expressing 
monocytes was slightly lower than normal in T1DM, with a further decrease after 
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activation with either lipopolysaccharide (LPS) or interferon gamma. These findings 
are not in agreement with the majority of authors, who have stressed the role of these 
same inflammatory mediators, cytokines and activators, in induction of adhesion 
molecules and in their mobilisation from intracellular granules (Springer et  al, 1984, 
Lanier, 1985, Bainton, 1987). LPS in particular is recognised as a ligand for integrins 
such as Mac-1.  There is general recognition that the endothelial dysfunction of 
T1DM causes production of cytokines that activate adhesion molecules and their 
ligands on endothelial cells and monocytes. 
Hoogerbrugge et al. (1996) found that monocytes from non-pregnant T1DM subjects, 
did not differ from those of healthy volunteers concerning their adhesion to 
endothelial cells in vitro, whereas the present study found that monocytes from 
pregnant women with T1DM expressed higher level of adhesion molecules Mac-1 
and LFA-1 than cells from normal pregnant subjects, and that this was associated with 
increased adhesion to endothelial cells isolated from the placental vascular bed 
directly involved in atherosis. 
 
4.7  Significance of the findings in this study 
 
Monocytes from normal pregnant women were exquisitely sensitive to even 
short-term stimulation by inflammatory and metabolic stimuli. Monocytes from 
pregnant women with T1DM have elevated levels of expression of adhesion 
molecules. We have previously shown that they have increased adhesiveness, and an 
augmented response to standard stimuli. This interaction between ß2 integrins and 
endothelial cell ICAMs is a critical step in the transition from cell rolling to firm 
arrest, and the findings of this study indicate prior priming of a nature conducive to 
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development and progression of atherosis of the placental bed blood vessels. 
Investigation of agents that can block Mac-1/ICAM-1 interactions may be of value in 
prevention or minimisation of this pathology. 
 
4.8    Potential future work examining monocyte-endothelial cell adhesion. 
 
A number of factors not studied in this body of work undoubtedly play a part 
in the adhesion of monocytes to endothelial cells. For example, chemoattractants such 
as MCP-1 belonging to the chemokine superfamily are produced and secreted by 
monocytes in response to activation or monocyte binding to endothelium. It is also 
likely that endothelial cell adhesion molecules are involved in increased monocyte-
DEC adhesion in diabetic pregnancy. ICAM-1 is a ligand for both Mac-1 and LFA-1. 
LFA-1 binds to domain 1 and Mac-1 binds to domain 3 (Staunton, 1989), (Marlin, 
1987), (Diamond 1991) (Xie, 1995). Certainly, an upregulation of DEC expression of 
ICAM-1 (the principal ligand for Mac-1) was seen in response to adherence of 
monocytes. Pre-treatment of monocytes by LPS resulted in upregulation of both Mac-
1 expression and monocyte adhesion, but not in further stimulation of DEC 
expression of ICAM-1, so other factors must be in play. ICAM-2, known to be a 
ligand for LFA-1, with controversial findings for Mac-1 (De Fougerolles, 1991) (Xie, 
1995), is also a molecule of interest. These are potential candidates for future work, 
but were not examined in the current study. 
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Appendix 1: List of Reagents 
The following list contains the source of general chemicals, cell culture and biological 
reagents, plastic ware and equipment. 
 
Cell Culture and Biological Reagents and General Chemicals 
 
Reagents/Chemical     Source 
 Antibodies 
 
Monoclonal mouse anti-human CD68 DAKO, Glostrup, Denmark 
(Clone EBM11) 
Monoclonal goat anti-mouse IgG  DAKO, Glostrup, Denmark 
Monoclonal mouse anti human CD45,  DAKO, Glostrup, Denmark 
Leukocyte Common Antigen                          DAKO, Glostrup, Denmark 
Monoclonal mouse anti-human CD14            DAKO, Glostrup, Denmark 
 
General Reagents/ Chemicals 
 
3’3’ Diaminebenzadine (DAB)  Sigma, St Louis, USA 
 
Ammonia Persulphate (APS)   Sigma, St Louis, USA 
 
Ammonium Chloride    Sigma, St Louis, USA 
 
Benzyl penicillin    Sigma, St Louis, USA 
 
Biotin (NHS-L6)    Pierce, Illinois, USA   
 
Bovine Serum Albumin   CSL, Parkville, Australia 
 
Dimethyl sulfoxide (DMSO)   Sigma, St Louis, USA 
 
Ethanol     Scharlau Chemie, Barcelona, Spain 
 
Fetal Bovine Serum (FBS), heat  Thermo Trace, Nobel Park, Australia 
 
Fetal Calf Albumin (FCA)   Invitrogen, Mount Waverley, Australia 
 
Fetal Calf Serum (FCS)   Sigma, St Louis, USA 
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Ficoll (type 400)    Pfizer, New York, USA 
 
Ficoll-Paque plus    Pfizer, New York, USA 
 
Formaldehyde     Sigma, St Louis, USA 
 
Glycergel     DAKO, Glostrup, Denmark 
 
Haematoxylin, Harris    Polysciences, Warrington, USA 
 
HBSS, without calcium and magnesium Sigma, St Louis, USA 
 
Hydrogen peroxide    Sigma, St Louis, USA 
 
PBS, tablets     ICN Biochemical’s, Cleveland, USA 
 
Sodium acetate (trihdrate)   Sigma, St Louis, USA 
 
Sodium bicarbonate    BDH Ltd, Poole, England 
 
Sodium carbonate (anhydrous)  Sigma, St Louis, USA 
 
Sodium chloride    Sigma, St Louis, USA 
 
Sodium EDTA- Disodium   Sigma, St Louis, USA 
 
Streptomycin     Sigma, St Louis, USA 
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      Hardware and Equipment 
 
 
 
Equipment 
 
3 ml Vacuette tube EDTA  Greiner, Frichenhausen, Germany 
 
3 ml Vacuette tube with clot activator Greiner, Frichenhausen Germany 
 
50 ml sterile tubes    BD Biosciences, Bedford, USA 
 
50 ml syringe    Terumo Medical, Elkton, USA 
 
Beckman Centrifuge J-21B 0-6000 rpm Beckman Instruments, Fullerton, USA 
 
Beckman elutriation chamber  Beckman Instruments, Fullerton, USA 
 
incorporated into a JE-6 rotor 
 
Beckman J2- HS centrifuge  Beckman Instruments, Fullerton, USA 
 
Class ΙΙ Biological Safety Cabinet Clyde-Apac Woodville, North Australia 
 
Clements GS 100     Clements, North Ryde, Australia 
 
Coverslip Glass Square 22x22 mm Menzel-Glazer, Germany 
 
Cryotube 1.8ml    Nunc, Roskilde, Denmark 
 
Cytospin centrifuge   Thermo Shandon Pitts burg, USA 
 
Haemocytometer-Improved Neubauer Sigma, St Louis, USA 
 
Incubator, 37 ºC, water jacketed, 5% Forma Scientific Inc., Marietta, USA  
 
CO2, model 3336  
 
Lamina flow hood    Gelman Science, Australia 
 
Micropipettes (1-10, 5-40)  Lab Systems, Helsinki, Finland 
 
Microwave oven, 650W   NEC, Australia 
 
MilliQ water purification system  Millipore, Molshein, France 
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Minisorp tubes    Nunc, Roskilde, Denmark 
 
Multichannel pipettes     Lab System, Helsinki, Finland 
 
Needles 19 G    Terumo Medical Corporation, Elkton, USA 
 
Needles 21 G miniset vein infusion set Baxter Healthcare Toongabbie, Australia 
 
Nikon CoolPix 990 digital camera Nikon, Tokyo, Japan 
 
Nikon Inverted Stage Microscope Nikon, Tokyo, Japan 
 
PAP pen      DAKO, Glostrup, Denmark 
 
Pasteur     Chase Instrument Corp., Glen Falls, USA 
 
PC Automate program   Flow Sciences, Inc., Wilmington, USA 
 
PCR tubes      Scientific Specialties Inc., Lodi, CA 
 
pH meter     Schott Gerate, Holfeim, Germany 
 
Pipette Aid    Drummond Scientific, Broomall, USA 
 
Syringes 5mL, 10mL, 50mL  Terumo Medical Corporation, Elkton, USA 
 
Transfer pipette disposable, Falcon BD Biosciences, Bedford, USA 
 
Tubes 15mL, 50mL, V- base, Falcon BD Biosciences, Bedford, USA 
 
Tubes Centrifuge 1.5ml Microfuge tube Eppendorf, Hamberg, Germany 
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